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CHAPTER I 
INTRODUCTION 
The world population of rattlesnakes consists of 
thirty-one species and seventy subspecies (Klauber, 1972), 
with six new subspecies awaiting recognition (Glenn and 
Straight, 1982). Of these, fifteen species and tweny-three 
subspecies reside in the United States (Glenn and Straight, 
1982). Rattlesnake venom poisoning represents a serious 
medical problem, both in the United States and throughout 
the world, though the significance of these problems vary. 
Lethal effects of venoms, obviously the most serious of 
sequelae, are not a major concern, statistically, in the 
United States. Parrish (1980) recorded only fifteen deaths 
out of 6,680 total rattlesnake bites, based on a survey of 
hospitals for the year 1959. This represents an 
approximate 0.2% fatality rate. Deaths due to poisonous 
snake bites are estimated to exceed 40,000 per year, 
however, throughout the world (Swaroop and Grab, 1956). 
There are two primary reasons for the markedly fewer deaths 
in the United States: 1) the exceedingly large number of 
medical facilities, which can usually be reached relatively 
quickly, and 2) the widespread use of Wyeth's polyvalent 
(Crotalidae) antivenin, an antiserum shown to be effective 
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in preventing lethal effects of many different snake venoms 
(Minton, 1954; Ownby et al., 1983; Russell et al., 1973). 
The major medical concerns in the United States are 
the local effects that often accompany rattlesnake venom 
poisoning. These effects include hemorrhage, myonecrosis, 
and edema, often leading to serious debilitation of the 
affected appendage. Local reactions to venom poisoning are 
due to a variety of toxins present in the venoms. 
Polyvalent antivenin has been shown to be effective against 
local hemorrhage (Ownby et al., 1984; Smith and Ownby, 
1985). However, this antivenom offers little protection to 
myonecrosis induced by some venoms (Ownby et al., 1983b), 
although Ownby and Colberg (1986) reported the 
neutralization of a significant dose of Crotalus atrox 
venom in mice. 
Current research includes studies on toxins present in 
venoms. These efforts include, among others, isolation and 
biochemical characterization of toxins, as well as studies 
on mechanisms of action and pathogenesis of the various 
sequelae. Because of the complexity of rattlesnake venoms, 
such research is no small task. The results of these 
multiple studies will hopefully aid in the development of 
more effective treatments, perhaps an antivenom capable of 
preventing or reducing not only lethal effects, but local 
reactions as well. 
As previously stated, hemorrhage is a major result of 
rattlesnake venom poisoning and has received a great deal 
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of attention in the literature. Current views on 
mechanisms of hemorrhage and characteristics of many 
hemorrhagic toxins thus far isolated are presented in the 
following chapter. One of these toxins, hemorrhagic toxin 
b (HTb), was originally isolated by Bjarnason and Tu (1978) 
from the venom of the western diamondback rattlesnake (~ 
atrox). It is characterized as a metalloprotease, 
requiring zinc for activity, representing approximately 
3.7% of the total venom protein. It is capable of inducing 
not only hemorrhage, but myonecrosis as well (OWnby et al., 
1978). The following paper describes the isolation of HTb. 
Also presented are procedures employed in the production 
and affinity purification of antibodies to this toxin, and 
the ability of these antibodies to neutralize hemorrhage 
induced by HTb. Venom samples from several species of 
snakes have been screened, using the enzyme-linked 
immunosorbent assay, for the presence of HTb, or cross-
reacting proteins, utilizing the affinity-purified 
antibodies. Finally, results of the immunohistochemical 
localization of this toxin in skeletal muscle are 
presented. 
CHAPTER II 
REVIEW OF LITERATURE 
In recent years, efforts of researchers have been 
directed at the isolation and characterization of snake 
venom components, largely due to the complexity of these 
venoms and the difficulty in studying the biological 
effects of the venoms as a result of their complex nature. 
Snake venoms are known to contain a wide variety of 
enzymes, mostly hydrolases, that include phospholipases, 
proteases, arginine esterases, phosphodiesterases, amino 
acid oxidases, deoxyribo- and ribonucleotidases, coagulant 
and anticoagulant factors (Iwanaga and Suzuki, 1979), and 
collagenases (Hong, 1982). Karlsson (1979) also points out 
the presence of nonenzymatic toxic proteins in venoms, such 
as the cardiotoxins and neurotoxins. Members of the 
Elapidae and Hydrophiidae families contain no known 
arginine esterase activities in their venoms, while venoms 
from elapids have little endopeptidase activity (Iwanaga 
and Suzuki, 1979). However, crotalid and viperid venoms 
contain extensive proteolytic and arginine esterolytic 
activities (Deutch and Diniz, 1955; Hamberg and Rocha E. 
Silva, 1957; Devi et al., 1959). Much of the clotting and 
bradykinin releasing activities, resulting in the 
4 
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hemostatic alterations typical of these venoms, have been 
shown to be due to the esterase activities of these venoms 
(Hamberg and Rocha E. Silva, 1957; Devi et al., 1959). The 
complexity of snake venoms becomes very obvious when one 
considers not only the above mentioned enzymatic 
constituents but also the pharmacological and biological 
effects of venoms. 
The effects of snake venoms on mammals have been 
extensively studied (Mebs, 1978), and there are many 
reports on the pharmacological and biological actions of 
venoms and their compnonets. These activities include: (1) 
hemorrhage, due to the presence of hemorrhagic toxins; (2) 
myonecrosis, due to myotoxins, and as a secondary effect to 
ischemia induced by hemorrhage; (3) hemostatic 
alterations, due to coagulant and anticoagulant enzymes; 
(4) effects due to neurotoxins; (5) cardiovascular 
compromise due to fluid loss during hemostatic alterations 
and hemorrhage as well as a result of the direct action of 
cardiotoxins; and (6) cytotoxic effects. Members of the 
Elapidae and Hydrophiidae families have venoms that result 
primarily in neurotoxic, myotoxic and cardiotoxic effects. 
Members of the Crotalidae and Viperidae families contain 
venoms that induce primarily hemorrhagic and myotoxic 
effects and hemostatic dysfunction. Exceptions to this 
general classification exist, including the two species 
Crotalus durissus terrificus and Crotalus scutulatus 
scutulatus, which are known to induce serious neurotoxic 
effects due to the presence in the venoms of crotoxin and 
mojave toxin, respectively. 
Some Biological Activities 
of Snake Venoms 
Hemorrhage: Hemorrhage is the most pronounced effect 
observed with rattlesnake venom poisoning and is an 
activity common to all viperid and crotalid snakes. 
Exceptions are c. s. scutulatus (Homma and Tu, 1971; Glenn 
-- --
et al., 1983) and Vipera russelli siamensis (Homma and Tu, 
1971). There are two mechanisms that allow loss of blood 
from the vascular system as a result of snake venom 
poisoning (OWnby, 1982): (1) through either damaged 
endothelial cells, hemorrhage per rhexis, and (2) through 
6 
widened intercellular junctions, hemorrhage per diapedesis. 
Crude c. atrox venom (OWnby et al., 1974), as well as three 
hemorrhagic toxins isolated from this venom, hemorrhagic 
toxins a, b, and e (Ownby et al., 1978), induce hemorrhage 
per rhexis. In an electron microscopy study, Ownby et al. 
(1978) described the pathogenesis of hemorrhage induced by 
these three toxins. Hemorrhagic toxins a and e both 
induced hemorrhage rapidly while hemorrhagic toxin b (HTb) 
demonstrated a latency period prior to the onset of 
hemorrhage. All three appeared to act directly on the 
endothelial cell, resulting in hemorrhage per rhexis. The 
endothelium after exposure to these toxins was described as 
having gaps adjacent to intact intercellular junctions, 
7 
with areas of the cell becoming very thin prior to rupture. 
The basal lamina was disrupted in all cases, and platelet 
aggregations were also typical (Ownby, 1982). The same 
type of necrosis was observed with the crude venom, 
although some myonecrosis was also present. In a recent 
study on the hemorrhagic proteinase HP-IV, isolated from 
the venom of c. horridus horridus (Civello et al., 1983a), 
OWnby and Geren (1987) showed that this toxin induced 
hemorrhage per rhexis. An intramuscular injection of the 
toxin caused hemorrhage within five minutes, resulting in 
gaps in the endothelial cells, many of which were severely 
swollen, especially at later time periods following 
injection of the toxin. Intact intercellular junctions 
were observed adjacent to damaged areas of the cells. Some 
regions of the basal lamina remained intact while other 
areas were disrupted. This toxin caused the release of 
proteins from the glomerular basement membrane (Civello et 
al., 1983b), an activity that may aid the hemorrhagic 
activity of the toxin. The toxin also induced hemolysis at 
all time periods, caused platelet aggregations, seen as 
thrombi in vessels, and resulted in fibrin deposition, an 
activity not observed with the hemorrhagic proteases 
isolated from~ atrox venom (Ownby et al., 1978). 
Hemorrhage per diapedesis is caused by the venom of 
Trimersurus flavoviridis. Ohsaka et al. (1975) showed in 
an electron microscopic study that erythrocytes leave the 
vascular compartment through widened intercellular 
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junctions following treatment with this venom. The 
endothelial cells remained intact. This type of hemorrhage 
was also demonstrated using the purified hemorrhagic 
component HR1, isolated from T. flavoviridis, using 
cinematographic and electron microscopic analyses (Tsychiya 
et al.,1974). According to Ohsaka et al. (1973), the 
movement of erythrocytes through widened intercellular 
junctions was aided by the fact that the hemorrhagic 
principles of the crude venom all disrupted the basement 
membrane (Ohsaka et al., 1973), compromising the structural 
integrity of the vessel wall. Also, the hemorrhagic 
principles, including HR1, HR2a, and HR2b, induce the 
release of vasoactive mediators, such as histamine and 
serotonin, from some organs and tissues, which may 
facilitate the widening of the junctions (Ishida et al., 
1975). 
Table I lists some of the hemorrhagic components 
isolated from snake venoms. Hemorrhagic toxins isolated 
from snake venoms are heterogeneous, having different 
isoelectric points and molecular weights. Kurecki and 
Kress (1985) reported the isolation of a single protein 
from the venom of c. adamanteus responsible for all 
hemorrhagic activity of that venom. This toxin, proteinase 
H, has a molecular weight of 85,700 daltons and an 
isoelectric point of 6.1. c. atrox venom, however, has at 
least seven hemorrhagic components, some with basic and 
some with acidic isolelectric points, with molecular 
Toxin Species 
HTa Crotalus 
atrox 
HTb Crotalus 
atrox 
HTc Crotalus 
atrox 
HTd Crotalus 
atrox 
HTe Crotalus 
atrox 
HTf Crotalus 
atrox 
HTg Crotalus 
atrox 
Protein H Crotalus 
adamanteus 
TABLE I 
SOME PROPERTIES OF HEMORRHAGIC TOXINS 
ISOLATED FROM SNAKE VENOMS 
Molecular Isoelectric Proteolytic 
Weight Point Activity 
68,000 acidic + 
24,000 basic + 
24,000 acidic + 
24,000 acidic + 
25,700 5.6 + 
64,000 7.7 + 
60,000 6.8 + 
85,000 6.1 + 
Reference 
Bjarnason and 
Tu (1978) 
Bjarnason and 
Tu (1978) 
Bjarnason and 
Tu (1978) 
Bjarnason and 
Tu (1978) 
Bjarnason and 
TU (1978) 
Nikai et al. 
(1984) 
Nikai et al. 
(1985) 
Kurecki and 
Kress (1985) 
TABLE I (Continued) 
Toxin Species Molecular Isoelectric Proteolytic Reference 
Weight Point Activity 
HP-IV Crotalus horridus 57,000 5.1 (-)casein Civello et al. 
horridus (+)hide powder (1983) 
Viriditoxin Crotalus viridis 115,000 4.8 + Fabiano and 
viridis Tu (1981) 
HF2 Bothrops 50,000 n.d. + Mandelbaum et 
~raraca al. (1976) 
NHFa Bothrops 46,000 4.2 + Mandelbaum et 
neuwiedi al. (1984) 
NHFb Bothrops 58,000 4.2 + Mandelbaum et 
neuwiedi al. (1984) 
AC1 Ag:kistrodon 24,500 4.7 + Nikai et al. 
acutus (1977) 
AC4 Ag:kistrodon 33,000 4.4 + Sugihara et al. 
acutus (1980) 
AC5 Ag:kistrodon 24,000 6.7 + Mori et al. 
acutus (1984) 
A a HI Ag:kistrodon 22,000 4.6 + Xu et al. 
acutus (1981) 
TABLE I (Continued) 
Toxin Species Molecular Isoelectric Proteolytic Reference 
Weight Point Activity 
AaHII Agkistrodon 22,000 5.3 + Xu et al. 
acutus (1981) 
AaHIII Agkistrodon 22,000 >9.0 + Xu et al 
acutus (1981) 
Proteinase B Agkistrodon halys 95,000 4.18 + Oshima et al. 
blomhoffii (1972) 
HR 1 Trimeresurus 104,000 4.3 (-)casein Omori-Satoh and 
flavorviridis (+)glomerular Ohsaka (1970) 
basement membrane Ohsaka et al. 
(1973) 
HR 2a Trimeresurus n.d. basic (-)casein Takahashi and 
flavoviridis (+)glomerular Ohsaka (1970) 
basement membrane Ohsaka et al. 
(1973) 
HR 2b Trimeresurus n.d. basic (-)casein Takahashi and 
flavoviridis (+)glomerular Ohsaka (1970) 
basement membrane Ohsaka et al. 
(1973) 
Mucrotoxin A Trimeresurus 94,000 4.3 + Sugihara et al. 
flavoviridis (1983) 
TABLE I (Continued) 
Toxin Species Molecular Isoelectric Proteolytic Reference 
Weight Point Activity 
HR 1 Trimeresurus 23,500 acidic + Ouyang and 
g:ramineus Huang (1979) 
HR 2 Trimeresurus 81,500 acidic + Huang et al. 
g:ramineus (1984) 
Hemorrhagin Viper a 44,000 acidic + Grotto et al. 
palestinae (1967) 
HR 1 Viper a 60,000 basic + ovadia (1978) 
Ealestinae 
HR 2 Vi:J2era 60,000 acidic + Ovadia (1978) 
Ealestinae 
HR 3 Vi:J2era 60,000 acidic n.d. Ovadia (1978) 
Ealestinae 
--
n.d. = not determined 
(-) = absence of proteolytic activity; (+) = presence of proteolytic activity 
weights ranging from 68,000 daltons to 24,000 da1tons 
(Bjarnason and Tu, 1978; Nikai et al., 1984; Nikai et al., 
1985). 
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Thus far, all hemorrhagic toxins isolated from 
crotalid venoms have proteolytic activity on a common 
substrate, such as casein or hide powder azure, with the 
exception of the three principles, HR1, HR2a, and HR2b, 
isolated from ~ flavoviridis venom. These principles do, 
however, cause the release of peptides and carbohydrates 
from the isolated glomerular basement membrane preparation 
(Ohsaka et al., 1973). The hemorrhagic protease, HP-IV, 
from ~ h. horridus venom, showed no activity on casein but 
did hydrolyze hide powder azure (Civello et al., 1983a). 
It has been pointed out that venom proteases often have 
very specific substrate requirements, and the lack of 
protease activity on one substrate is not exclusive to 
activity on another substrate (Bjarnason and Tu, 1978; 
Civello et al., 1983b). With time, it may become evident 
that all hemorrhagic toxins are proteolytic on one type of 
substrate or another (Bjarnason and Tu, 1978; Huang and 
Perez, 1980). There is some question as to the 
relationship between proteolytic activity and hemorrhagic 
activity. Bjarnason and Tu (1978) found that there was an 
inverse relationship between the hemorrhagic activity and 
proteolytic activity of hemorrhagic toxin a. Fox et al. 
(1986) proposed that the major step leading to snake-venom 
induced hemorrhage "appears to be the disruption of the 
14 
pericellular collagenous basement membrane and other 
connective tissue collagens by proteolytic toxins ••• ," 
though Civello et al. (1983b) detected no collagenous 
activity of HP-IV, a potent hemorrhagin isolated from the 
venom of c. h. horridus (Civello et al., 1983a). The toxin 
did, however, cause the release of proteins from the 
glomerular basement membrane preparation (Civello et al., 
1983b). The differences in the mechanisms of action 
leading to hemorrhage, i.e., hemorrhage per rhexis or 
diapedesis, however, indicates the need for more work 
before a clear classification of the actions of hemorrhagic 
toxins can be made. 
Myonecrosis: Myonecrosis is a complicated sequelae to 
snake venom poisoning. It results from the direct action 
of toxins on muscle (Ownby, 1982) and may result from the 
indirect effect of ischemia due to hemorrhagic components 
in the venoms (Gleason et al., 1983). There are several 
reports of myonecrosis following poisonous snakebites, and 
all four families of snakes are known to have venoms 
capable of damaging muscle (Reid, 1964; Tu, 1977; Campbell, 
1979; Efrati, 1979; Reid, 1979). In a report by Homma and 
Tu (1971), of 37 crotalid, viperid and elapid venoms 
tested, all induced the necrosis of muscle except one 
elapid, Ophiophagus hannah. Also in this report, Homma and 
Tu (1971) proposed the classification of skeletal muscle 
necrosis based on light microscopic observations into the 
following categories: (1) myolytic necrosis - typical of 
15 
elapid venoms, is characterized by the presence of dense, 
clumped myofilaments; (2) coagulative necrosis - typical of 
viperid and crotalid venoms, demonstrates a hyaline, 
amorphous appearance of the cell; and (3) mixed necrosis -
typical of crotalid venoms, is characterized by the 
presence of cells undergoing both myolytic and coagulative 
necrosis. However, in all cases, no "completely pure type 
of muscle necrosis" was present. The fact that all samples 
were taken at 24 hours following injection may indicate 
that the types of necrosis described may represent a 
sequential series of steps or stages leading to necrosis 
and cellular death (Ownby, personal communication). The 
resolution of this question requires a study involving the 
sampling of tissue at various times following injection to 
discern a pattern of necrosis, if such a pattern of 
sequential stages does exist. There have been several 
myotoxic components isolated from snake venoms. Table II 
presents some of these toxins. 
Cardiotoxic Myotoxins: The cardiotoxins are small 
polypeptides that are frequently referred to as membrane 
active proteins (Chang, 1979). Experimental evidence 
indicates that these toxins bind the cell membrane, 
possibly through electrostatic interactions, and then 
insert a hydrophobic portion of it's molecule into the 
membrane, disrupting the membranal integrity (Klibansky et 
al., 1968; Dufourcq et al., 1982). These toxins are also 
directly hemolytic (Mebs, 1978). There have been several 
Toxin 
Myotoxin ~ 
Crotamine 
Peptide C 
Myotoxin I 
Myotoxin II 
HTb 
Species 
Crotalus viridis 
-----
viridis 
Crotalus durissus 
terri ficus 
Crotalus viridis 
helleri 
Crotalus viridis 
concolor 
Crotalus viridis 
concolor 
Crotalus 
atrox 
TABLE II 
MYOTOXIC COMPONENTS ISOLATED 
FROM SNAKE VENOMS 
Molecular pi Enzymatic/Toxic 
Weight Activities 
SMALL BASIC MYOTOXINS 
4,400 9.6 Hemolytic 
4,900 >10.3 None 
4,990 >10 Vasculo-
toxic 
4,500 >10.6 None 
n.d. >10.6 None 
HEMORRHAGIC MYOTOXINS 
24,000 basic Protease 
Hemorrhagic 
Reference 
Cameron and Tu (1977) 
Ownby et al. (1976) 
Goncalves (1956) 
Maeda et al. (1978) 
Russell et al. (1978) 
Engle et al. (1983) 
Engle et al. (1983) 
Bjarnason and Tu 
(1978) 
TABLE II (Continued) 
Toxin Species Molecular pi Enzymatic/Toxic Reference 
Weight Activities 
Viriditoxin Crotalus viridis 115,000 4.8 Protease Gleason et al. 
viridis Hemorrhagic (1983) 
Mucrotoxin A Trimersurus 94,000 4.3 Protease Sugihara et al. 
flavoviridis Hemorrhagic (1983) 
PHOSPHOLIPASE MYOTOXINS 
Myotoxin Agkistrodon 15,070 acidic Phospholipase Mebs and Samejima 
bilineatus (1986) 
Myotoxin Agkistrodon 14,570 acidic Phospholipase Mebs and Samejima 
mokeson (1986) 
Myotoxin Agkistrodon 13,720 acidic Phospholipase Mebs and Samejima 
piscivorus (1986) 
Myotoxin Bothrops 10,700 basic Phospholipase Gutierrez et al. 
as per Hemolytic (1984a) 
Myotoxin Bothrops 16,000 basic None Gutierrez et al. 
nummifer (1986) 
Crotoxin Crotalus durissus 24,550 4.7 Phospholipase Breithaupt et al. 
terri ficus Neurotoxic (1974) 
TABLE II (Continued) 
Toxin Species Molecular pi Enzymatic/Toxic Reference 
Weight Activities 
Mojave toxin Crotalus 22,700 acidic Phospholipase Cate and Bieber 
scutulatus Neurotoxic (1978) 
Myotoxin Trimersurus 13,914 acidic Phospholipase Mebs and Samejima 
flavoviridis (1986) 
Notexin Notechis 13,500 acidic Phospholipase Karlsson et al. 
scutatus Neurotoxic (1972) 
Taipoxin oxyuranus 46,700 5.0 Phospholipase Fohlman et al. 
scutellatus Neurotoxic (1976) 
Mulgotoxin A Pseudechis 13,710 9.8 Neurotoxic Leonardi et al. 
australis (1979) 
Myotoxin Pseudechis 13,400 basic Phospholipase Mebs and Samejima 
VIII A australis Neurotoxic (1980) 
Myotoxin IB Pseudechis 13,400 basic Phospholipase Mebs and Samejima 
porphyriacus Neurotoxic (1980) 
Myotoxin IV Pseudechis 14,100 basic Phospholipase Mebs and Samejima 
colletti Neurotoxic (1980) 
Myotoxin Enhydrina 13,500 basic Phospholipase Fohlman and Eaker 
VI:5B schistosa (1977) 
n.d.=not determined 
none=no activity detected 
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studies on muscle degeneration following experimental 
envenomation with crude venoms and purified toxins. 
Stringer et al. (1971) studied the local effects following 
intramuscular injection of Naja naja kaouthia venom, a 
venom known to contain a cardiotoxin (Sarkar, 1947) and 
capable of inducing local necrosis in humans (Reid, 1964). 
At the light microscopic level, the venom induced the 
myolytic type of necrosis. Ultrastructurally, the 
mitochondria were described as being dramatically altered, 
containing dense material and clearly altered cristae. The 
sarcomeres became disrupted and the sarcoplasmic reticulum 
was fragmented and vacuolated. The degeneration appeared 
to be due to the cardiotoxin present in this venom 
(Stringer et al., 1971), potentiated by phospholipases (Lai 
et al., 1972). 
Small Basic Myotoxins: Necrosis of skeletal muscle 
is also due to the presence of small molecular weight 
toxins, represented by myotoxin ~' isolated from c. viridis 
viridis venom (Ownby et al., 1976; Cameron and Tu, 1977). 
This family of toxins have low molecular weights, around 
4000 daltons, are highly basic, and have been isolated from 
the venoms of ~ ~ terrificus (Gonclaves, 1956; Cameron 
and Tu, 1978; Beltran et al., 1985), ~ ~ concolor (Engle 
et al., 1983), and~ v. helleri (Russell et al., 1978). 
The pharmacological action of these toxins indicates a 
possible interaction with the sodium-potassium ATPases 
found in the sarcoplasmic reticulum (Ownby et al., 1976; 
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Chang and Tseng, 1978; Hong and Chang, 1985), though recent 
studies showed an interaction of myotoxin ~ with the 
calcium ATPase of the sarcoplasmic reticulum (Liddle and 
Tu, 1985). Stringer et al. (1972) published the first 
report describing the ultrastructural changes in muscle 
resulting from rattlesnake venom. C. v. viridis venom, 
known to contain myotoxin ~(Ownby et al., 1976), was the 
venom studied. An intramuscular injection of a one-fourth 
Ln50 was the selected dose. Initial changes included 
dilatation of the normally flattened sarcoplasmic 
reticulum, followed by disintegration of the vacuolated 
sarcoplasmic reticulum into small vesicles. The 
myofilaments became disrupted with the disappearance of the 
H and M bands, followed by disruption of the Z line. The 
basal lamina and the sarcolemma remained unaffected until 
late in the degenerative stages. The effect of purified 
myotoxin ~ was also studied at the ultrastructural level 
(Ownby et al., 1976). Vacuolation of the muscle cells was 
first observed at six hours following the intramuscular 
injection of a 1.5 mg/kg dose in mice. By 72 hours, 
complete vacuolation and loss of normal striations were 
observed. The vacuolation observed at the light 
microscopic level was attributed to dilatation of the 
sarcoplasmic reticulum and widening of the perinuclear 
space. By 48 hours, the sarcoplasmic reticulum vacuoles 
had broken down into many smaller vacuoles, though the T-
tubules appeared normal. Mitochondria demonstrated some 
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swelling and the myofibrillar structure was becoming 
compromised. By 72 hours, normal sarcomeric structure was 
dissolved. The basal lamina and sarcolemma of the necrotic 
cells, however, remained intact. 
Phospholipase Myotoxins: A third group of toxins 
present in many venoms capable of inducing myonecrosis are 
the phospholipases. It has been proposed that these toxins 
may cause necrosis, as well as neurotoxicity, by altering 
calcium transport across nerve and muscle plasma membranes, 
the sarcoplasmic reticulum, and into mitochondria (Ng and 
Howard, 1980). These toxins are represented by notexin, 
from Notechis scutatus venom (Karlsson et al., 1972; Harris 
and MacDonnell, 1981), taipoxin, from Oxyuranus scutellatus 
venom (Fehlman et al, 1976), and crotoxin, from~~ 
terrificus venom (Slotta and Fraenkel-Conrat, 1939). 
Although these toxins all have phospholipase activity and 
induce myonecrosis, there are distinct pharmacological and 
biochemical differences between them. Notexin is a single 
polypeptide neurotoxin capable of inhibiting the release of 
the presynaptic neurotransmitter acetylcholine (Harris et 
al., 1975). Taipoxin is a complex protein consisting of 
three subunits, also capable of inhibiting the release of 
acetylcholine (Fehlman et al., 1976; Harris and Maltin, 
1982). Crotoxin is a protein having two subunits, one of 
which is a basic phospholipase, capable of causing 
myonecrosis (Gopalakrishnakone and Hawgood, 1984; 
Kouyoumdjian et al., 1986). The other subunit, which is 
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nontoxic by itself and acidic, is capable of increasing the 
toxicity of the basic subunit when complexed with it, 
apparently by preventing the non-specific attachment to 
receptor sites (Habermann and Breithaup, 1978; Bonet al., 
1982). Crotoxin is a potent neurotoxin which also damages 
the neuromuscular junction (Gopalakrishnakone et al., 1979; 
Gopalakrishnakone et al., 1980; Gopalakrishnakone and 
Hawgood, 1984). Other venoms from which myotoxic 
phospholipases have been isolated include ~ scutulatus 
(Bieber et al., 1975; Cate and Bieber, 1978), Pseudechis 
australis (Leonardi et al., 1979), ~ porphyriacus (Mebs 
and Samejima, 1980), Bothrops asper (Alagon et al., 1980; 
Gutierrez et al., 1984a), ~ flavoviridis (Mebs and 
Samejima, 1986), and Agkistrodon piscivorus (Welches et al, 
1985; Mebs and Samejima, 1986). 
The pathogenesis of myonecrosis induced by the venoms 
containing phospholipases has been studied using the 
electron microscope. Harris and Maltin (1982) described 
the myonecrosis following injection of Oxyuranus 
scutellatus venom, known to contain taipoxin. The plasma 
membrane was disrupted by one hour, and myofibrils were 
hypercontracted, giving rise to the myolytic necrosis 
described by Homma and Tu (1971). The basal lamina 
appeared unaffected. Within three hours, phagocytic cells 
had invaded the area and were often located within necrotic 
muscle cells. The toxin notexin, from Notechis scutatus, 
presents a histological picture very similar to that 
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described above. Because notexin is capable of hydrolyzing 
synthetic and membrane phospholipids (Harris and MacDonell, 
1981), the mode of action leading to necrosis is most 
likely due to the destruction of the muscle cell plasma 
membrane. Gutierrez et al. (1984b) have reported the 
pathogenesis of myonecrosis induced by ~ asper venom. 
This venom, which contains a myotoxic phospholipase 
(Gutierrez et al., 1984b), irreversibly damaged muscle 
cells within 30 minutes. Like Oxyuranus scutellatus venom, 
the crude venom and the myotoxic phospholipase destroyed 
the plasma membrane but in the absence of basal lamina 
damage. An influx of calcium following venom injection 
(Gutierrez et al., 1984b) presented further evidence that 
the venom acted on the muscle cell membrane leading to 
myonecrosis. The muscle cells were described as being of 
the myolytic type at early time periods, but by three 
hours, the myofibrils were more loosely packed, giving rise 
to a hyaline appearance. With both the toxin and crude 
venom, the mitochondria were severely affected. Many were 
swollen with vesiculated cristae, while others had 
flocculent densities. The sarcoplasmic reticulum and T-
tubules were also affected, resulting in small vesicles 
dispersed throughout the cytoplasm. 
Hemorrhagic Myotoxins: Another group of toxins found 
in snake venoms that are described as being directly 
myotoxic are the hemorrhagic myotoxins. Only three such 
toxins have been reported: HTb from c. atrox venom 
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(Bjarnason and Tu, 1978), viriditoxin (Fabiano and Tu, 
1981) and viriditoxin-variant (Gleason et al., 1983), 
isolated from ~ ~ viridis venom, and mucrotoxin A, from 
T. flavoviridis venom (Sugihara et al., 1983). HTb has 
been previously described. Viriditoxin and viriditoxin-
variant are described as high molecular weight (115,000 
daltons) acidic proteins consisting of two subunits. The 
two toxins are very similar, but differences in amino acid 
compositions and stoichiometric relationships between the 
two subunits are reported (Gleason et al., 1983). 
Mucrotoxin A is an acidic protein with a molecular weight 
of 94,000 daltons. Myonecrosis three hours post-injection 
has been reported for both HTb (OWnby et al., 1976) and 
mucrotoxin A (Kishida et al., 1985). In the case of 
viriditoxin, myonecrosis was reported, but only after 24 
hours post-injection (Fabiano and Tu, 1981). An important 
question concerning these toxins involves the relationship 
between ischemia and myonecrosis and whether these toxins 
cause myonecrosis directly or if the necrosis results from 
the compromised blood flow with the onset of ischemic 
conditions, since these toxins are all hemorrhagic. 
Ischemic conditions have been shown to cause necrosis and 
death of myocardial cells (Jennings and Reimer, 1981). 
Also, ischemia alters the membrane structure in liver cells 
which react much like the myocardial cell sarcolemma that 
has been exposed to ischemic conditions (Farber et al., 
1981). Ischemic conditions result in the accelerated 
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degradation of phospholipids from the cellular plasma 
membrane and the endoplasmic or sarcoplasmic reticulum, 
disrupting the integrity of the membrane with the influx of 
calcium, leading eventually to cell death (Farber et al., 
1981). In myocardial tissue exposed to severe ischemia, 
the mitochondria have been described as being swollen, 
having distorted cristal arrangements and containing dense 
matrix granules (Jennings and Reimer, 1981). Similar 
descriptions of skeletal muscle injected with hemorrhagic 
toxins (OWnby et al., 1978) and crude snake venom (Stringer 
et al, 1972) have been reported. Ownby et al. (1978) 
reported the presence of intact capillaries adjacent to 
necrotic muscle cells three hours following injection of 
HTb, indicating a possible direct myolytic action of the 
toxin. In contrast, Gleason et al. (1983) reported for 
viriditoxin that the necrosis of muscle was most likely due 
to indirect ischemic conditions since necrosis was observed 
only after the destruction of blood vessels and the 
apparent onset of such conditions. 
Activities and Composition 
of Crotalus atrox Venom 
C. atrox venom has been shown to induce a wide variety 
of biological effects, including hemorrhage, myonecrosis, 
and hemostatic alterations. The complexity of ~ atrox 
venom is typical of most crotalid venoms, containing many 
toxins with a variety of activities. Table III lists some 
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of the activities that have been identified for crude c. 
atrox venom. Table IV is a list of the components that 
have been isolated from c. atrox venom to date. All of the 
components have some type of toxic or enzymatic activity, 
excepting nerve growth factor. The primary technique used 
to isolate the toxins was column chromatograpy, including 
anion and cation exchange chromatography, gel filtration 
chromatography, and hydrophobic interaction chromatography. 
Hemorrhage: All rattlesnake venoms thus far studied 
induce hemorrhage, with the exception of ~ ~ scutulatus 
venom. This activity of ~ atrox venom is due to the 
presence of seven hemorrhagic toxins isolated from the 
venom, hemorrhagic toxins a, b, c, d, e, f, and g 
(Bjarnason and Tu, 1978; Nikai et al., 1984; Nikai et al., 
1985). These toxins ranged in molecular weights from 
24,000 daltons to 68,000 daltons. Five had acidic 
isoelectric points, HTf was almost neutral (pi 7.7), while 
HTb was very basic. All of the toxins are 
metalloproteases; both proteolytic and hemorrhagic 
activities were inhibited by treatment with 
ethylenediaminetetraacetic acid (EDTA). The proteolytic 
specificities for hemorrhagic toxins a, b, c, and d have 
been determined on oxidized insulin B chain. Hemorrhagic 
toxins b, c, and d cleaved the substrate at five identical 
sites (Hagihara et al., 1985; Fox et al., 1986). Toxins c 
and d may be isozymes since both are acidic and have 
similar molecular weights (Bjarnason and Tu, 1978). HTb 
TABLE III 
SOME ACTIVITIES OF CROTALUS ATROX VENOM 
Activity 
Proteolytic 
Esterolytic 
Collagenolytic 
Phosphodiesterolytic 
Phosphomonoesterolytic 
Hemorrhagic 
Myotoxic 
Phospholipolytic 
Oxidation of L-amino acids 
Hypotension and Cardiotoxic 
Fibrinogenolytic 
Fibrinolytic 
Fibrinogen clotting 
Anticoagulant 
Procoagulant 
Hemolytic and Cytotoxic 
Platelet aggregation 
Selected Reference 
Wagner and Prescott (1966) 
Simpson and Taylor (1973) 
Simpson and Rider (1971) 
Richards et al. (1965) 
Richards et al. (1965) 
OWnby et al. (1974) 
Huang and Perez (1982) 
Wu and Tinker (1969) 
Kocholaty et al. (1971) 
Posner et al. (1981) 
Pandya et al. (1983) 
Bajwa et al. (1981) 
Pfleiderer and Sumyk (1961) 
Pandya and Budzynski (1984) 
Pfleiderer and Sumyk (1961) 
Tu (1977) 
Ownby et al. (1974) 
Toxin Activities 
HTa Hemorrhage 
HTb Hemorrhage 
HTc Hemorrhage 
HTd Hemorrhage 
HTe Hemorrhage 
HTf Hemorrhage 
HTg Hemorrhage 
Hypotensin Hypotensive 
MDP Myocardial 
depressant 
TABLE IV 
TOXINS ISOLATED FROM THE VENOM 
OF CROTALUS ATROX 
Molecular pi Characteristics/ 
Weight Enzymatic Activity 
68,000 acidic Metalloprotease 
24,000 basic Metalloprotease 
24,000 acidic Metalloprotease 
24,000 acidic Metalloprotease 
25,700 5.6 Metalloprotease 
64,000 7.7 Metalloprotease 
60,000 6.8 Metalloprotease 
n.d. n.d. Nonenzymatic 
10,000 n.d. Nonenzymatic 
Reference 
Bjarnason and 
Tu (1978) 
Bjarnason and 
Tu (1978) 
Bjarnason and 
Tu (1978) 
Bjarnason and 
Tu (1978) 
Bjarnason and 
Tu (1978) 
Nikai et al. (1984) 
Nikai et al. (1985) 
Bonilla (1976) 
Bonilla and 
Rammel (1976) 
TABLE IV (Continued) 
Toxin Activities Molecular pi Characteristics/ Reference 
Weight Enzymatic Activity 
PR I Anti- 20,000 basic Fibrinolytic Pandya and 
coagulant Metalloprotease Budzynski (1984) 
PR II Anti- 31,000 acidic Fibrinolytic Pandya and 
coagulant Metalloprotease Budzynski (1984) 
PR III Anti- 24,000 acidic Fibrinolytic Pandya and 
coagulant Metalloprotease Budzynski (1984) 
PR IV Anti- 46,000 acidic Fibrinolytic Pandya and 
coagulant Metalloprotease Budzynski (1984) 
Alpha- Protease n.d. n.d. Inhibited by EDTA Pfleiderer and 
proteinase Clots fibrinogen Sumyk (1961) 
Beta- Protease n.d. n.d. Inhibited by Pfleiderer and 
proteinase EDTA Sumyk (1961) 
Gamma- Protease n.d. n.d. Inhibited by Pfleiderer and 
proteinase EDTA Sumyk (1961) 
Enzyme Phospho- 29,500 acidic Dimer Hachimori et al. 
lipase (1971) 
Q1 Anti- 19,200 n.d. Acts directly Man and Minta 
complement on complement (1977) 
TABLE IV (Continued) 
Toxin Activities Molecular pi Characteristics/ Reference 
Weight Enzymatic Activity 
Q2 Anti- 14,500 n.d. Acts directly Man and Minta 
complement on complement (1977) 
Q3 Anti- 12,600 n.d. Acts directly Man and Minta 
complement on complement (1977) 
Q4 Anti- 55,000 n.d. Acts directly Man and Minta 
complement on complement (1977) 
EI Esterase 27,500 4.7 Releases Bjarnason et al. 
bradykinin (1983) 
EII Esterase 29,200 4.3 Releases Bjarnason et al. 
bradykinin (1983) 
Fibrino- Esterase 31,000 4.6 Fibrinolytic Nikai et al. 
genase Protease (1983) 
Enzyme Collagenase 58,000 5.1 PZ-peptidase Hong (1981) 
NGF Nerve growth 40,000 n.d. nonenzymatic Angeletti (1968) 
n.d. = not determined 
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also hydrolyzed fibrinogen, although it was different from 
thrombin and did not produce a fibrin clot (Komori et al., 
1985). Hemorrhagic toxin a also cleaved oxidized insulin B 
chain, sharing four common cleavage sites with HTb (Fox et 
al., 1986). 
Ownby et al. described the pathogenesis of hemorrhage 
induced by the crude venom (1974) and by the three toxins 
HTa, HTb, and HTe (1978). In all cases, the hemorrhage was 
per rhexis, meaning the erythrocytes escaped the vascular 
compartment through gaps in the endothelial cell wall, not 
through widened intercellular junctions. The pathogenesis 
of hemorrhage induced by the venom and these three toxins 
has been previously described. 
Perhaps associated with hemorrhage is the presence of 
a collagenase in the venom, which has been characterized as 
having a molecular weight of 58,000 and an isoelectric 
point of 5.1. The toxin also hydrolyzed the PZ-peptidase 
substrate (Hong, 1982). Disruption of the basal lamina may 
aid in the induction of hemorrhage (Ohsaka et al., 1973; 
Fox et al., 1986). The collagenolytic activity of the 
venom due to this component may be responsible for the 
d~sruption of the basal lamina described by Ownby et al. 
(1974), resulting in the weakening of the vessel wall, 
aiding the extravasation of erythrocytes. 
Myonecrosis: c. atrox venom (Homma and Tu, 1971; 
Ownby et al., 1974), as well as HTb (Ownby et al.,1978), 
cause myonecrosis. Thus far, HTb is the only directly 
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acting myotoxin isolated from this venom. Many 
phospholipases isolated from snake venoms are known to 
induce myonecrosis (Karlsson et al., 1972; Gutierrez et 
al., 1984a; Mebs and Samejima, 1986). Only one 
phospholipase has been isolated from ~ atrox venom, a 
protein with a molecular weight of 29,500 daltons with an 
acidic isoelectric point (Wu and Tinker, 1969; Hachimori et 
al., 1971). However, there is no report in the literature 
that this toxin causes myonecrosis. One feature of 
myonecrosis induced by a phospholipase from ~ asper venom 
was the presence of "delta lesions," wedged shape areas 
seen at the light microscopic level in skeletal muscle, 
resulting from damage to the plasma membrane of the cell 
(Gutierrez et al., 1984b). Myonecrosis induced by crude c. 
atrox venom demonstrated lesions that appeared similar to 
these delta lesions (Ownby, personal communication), though 
it is unknown what toxin or toxins caused the lesions. One 
possibility is the presence of a cofactor or associated 
protein required by the phospholipase for activity and 
subsequently myonecrosis. 
Hemostatic Alterations: By far, the largest number 
and types of toxins and components isolated from ~ atrox 
venom are those that have some effect on normal hemostasis. 
These effects include the release of vasoactive compounds 
such as bradykinin, anti-coagulant and fibrinolytic 
activities, procoagulant activities, the induction of 
increases in capillary permeability, platelet aggregation, 
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and cardiotoxic and hypotensive effects. 
Posner et al. (1981) demonstrated that c. atrox has 
cardiotoxic activity, showing that the venom could reduce 
the action potential amplitude, action potential duration, 
and the resting membrane potential of feline papillary 
muscle and Purkinje fibers. The maximum developed tension 
of papillary muscle was also significantly reduced. All of 
these factors would result in a potent depression of 
cardiac output, contractile force, and heart rate, 
resulting in a severe systemic arterial pressure 
hypotension, dramatically altering normal hemostasis. 
Bonilla and Rammel (1976) isolated from the venom a protein 
called myocardial depressor protein. It is characterized 
as an acidic protein containing no known proteolytic, 
esterolytic, or phospholipolytic activities, capable of 
severely depressing arterial pressure and cardiac output. 
Also in this venom is a very small molecular weight peptide 
(20 amino acids), known as hypotensin, which induces an 
immediate decrease in systemic arterial pressure upon 
injection (Bonilla, 1976). 
Pandya and Budzynski (1984) isolated four 
metalloproteases, PR I, PR II, PR III, and PR IV, that were 
anticoagulant, capable of degrading fibrinogen, though no 
fibrin clot was formed, indicating activities different 
from thrombin. The molecular weights ranged from 20,000 to 
46,000 daltons, and all had acidic isoelectric points, 
except PR I, which was basic. Nikai et al. (1983) reported 
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the isolation of fibrinogenase, a toxin with a molecular 
weight of 31,000 daltons and an isoelectric point of 4.6. 
It had both proteolytic and esterolytic activities, caused 
an increase in capillary permeability, degraded fibrinogen, 
and released bradykinin from kininogen. This toxin is 
probably PR II, isolated by Pandya and Budzynski (1984), 
which also has a molecular weight of 31,000 daltons and an 
acidic isoelectric point. Two other kallikrein-like 
proteins that release bradykinin from kininogen have been 
isolated from c. atrox venom (Bjarnason et al., 1983). 
These toxins, EI and EII, had respective molecular weights 
of 27,000 and 29,200 daltons. Their reported isoelectric 
points were 4.7 and 4.3, respectively. Both proteins had 
arginine esterase activity. Bradykinin is a potent 
vasodilator and causes an increase in vascular 
permeability, both of which would induce hypotension. 
Bradykinin is also the most probable source of pain 
associated with rattlesnake venom poisoning (Ownby, 1982). 
Looking at the fibrinolytic and fibrinogen clotting 
enzymes in ~ atrox, Bajwa et al. (1981) found ony two 
fibrinolytic enzymes. Their molecular weights were 60,000 
and 21,500 daltons. No fibrin clot forming activity was 
found. Pfleiderer and Sumyk (1961), however, reported the 
presence of a fibrinogen clotting metalloprotease, alpha-
protease, which was inhibited by EDTA. The differences in 
these reports may be due to variations in individual snake 
venoms. Pfleiderer and Sumyk (1961) also reported the 
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isolation of two other metalloproteases, beta-protease and 
gamma-protease, although these had no effect on fibrinogen. 
c. atrox venom also induced platelet aggregation and 
thrombi formation (OWnby et al., 1974), although no 
purified toxin responsible for this activity has been 
reported. 
Other Isolated Components: Man and Minta (1977) 
reported the isolation of four toxins, Q1, Q2, Q3, and Q4, 
that act directly on complement factors. Although no 
enzymatic activities were determined, the toxic effects 
were inhibited by EDTA, indicating the need of metal ions 
for activity. The effects of the toxins appeared to be due 
to the direct action on complement factors, inhibiting the 
activation of the complement sequence. 
Angeletti (1968) reported the isolation of nerve 
growth factor from ~ atrox venom, having an approximate 
molecular weight of 40,000 daltons. No enzymatic activity 
was determined for the factor. 
Lethal Toxicities: There are many papers that report 
the LD50 values for ~ atrox venom, tested using 
intravenous, intraperitoneal, and subcutaneous injections. 
These values range from 1.0 mg/kg (i.v.) to 28.0 mg/kg 
(s.c.). Table V lists some of the reported LD50 values for 
c. atrox venom, determined using the above three routes of 
injection in mice. 
Route 
i.v. 
2.66 
4.20 
3.56 
1.0 
LD50 mg/kg 
TABLE V 
REPORTED LETHAL TOXICITIES 
OF CROTALUS ATROX VENOM 
Reference 
of Injection 
hE..!. S.C. 
4.26 Kochalaty et al. (1971) 
3.71 Emery and Russell (1963) 
8.42 19.25 Minton (1956) 
28.0 Minton (1975) 
5.5 * Macht (1937) 
16.11 Schoettler (1951) 
3.7 Freiderich and Tu (1971) 
4.8 Glenn et al. (1972) 
Theakston and Reid (1978) 
4.5 Glenn and Straight (1978) 
8.0 Perez et al. (1978) 
* Minimum lethal dose 
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Treatments of Snake Venom Poisoning 
An important reason for studying snake venoms is to 
develop better methods of treating snake bites in the 
clinical case. There are several methods used to treat 
snake venom poisoning, each of which has apparent 
attributes as well as problems. The major problem facing 
the treating physician, however, is the fact that no two 
snake bite cases present the same problem. There are many 
factors which influence an individual's response to a snake 
bite, all of which must be considered by the attending 
physician. These factors include the quantity of venom 
injected, the health of the individual, the depth and 
location of the bite, and the time between the bite and the 
treatment (Minton, 1954). Each of these factors must be 
considered by the physician when choosing a particular 
treatment. 
Pressure-Immobilization: One treatment advocated by 
some researchers is the pressure-immobilization technique, 
which involves wrapping the bitten limb tightly with a 
bandage and immobilization with a splint (Sutherland and 
Coulter, 1981; Glenn and Straight, 1985). Sutherland and 
Coulter (1981) measured a delay in the movement of the 
venom in experimentally treated monkeys using radioimmune 
assays. One problem with this technique, however, would be 
the potential of concentrating within a small area those 
toxins present in the venom capable of inducing serious 
local effects, such as hemorrhage, edema and myonecrosis. 
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Ligature-Cryotherapy: Similar to the pressure-
immobilization technique is the ligature-cryotherapy 
method, involving the placement of a ligature around the 
affected limb and immersion into a cold environment 
(Stahnke et al., 1957; Stahnke and McBride, 1966). Stahnke 
(1981) proposed that since most enzymes present in the 
venoms are active at temperature between 37 and 45 degrees 
centigrade, the cryotherapy technique would prevent or 
reduce the activity of these enzymes. Karlsson (1979), 
however, presented the point that many toxins present in 
snake venoms capable of inducing various effects are not 
enzymes. Myotoxin ~, for example, is a nonenzymatic 
component capable of inducing serious myonecrosis (OWnby et 
al., 1976; OWnby, 1982). Often, the combination of the 
toxins and the tissue-damaging effects of the cold 
environment proves to cause more damage to the affected 
limb than the toxins in the venom alone left untreated 
(Arnold, 1982). 
Surgical Intervention: Surgical intervention is often 
the treatment selected, and includes incision-suction and 
debridement and fasciotomy. There is some concern, 
however, in the amount of venom injected in a given bite. 
sutherland and Coulter (1981) estimate that approximately 
26% of the snake bites in the United States result in no 
venom deposition, cases in which surgical intervention is 
certainly contraindicated. Yet there are physicians that 
propose the use of surgery in all cases of snake bite 
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(Glass, 1976). Incision-suction, where an incision is made 
at the site of venom injection and direct suction is 
applied, is used in hopes of removing as much of the venom 
as possible. The effectiveness of this treatment requires 
administration very soon if not immediately after poisoning 
(McCollough and Gennaro, 1970; Russell et al., 1973; 
Efrati, 1979). The second surgical method includes 
debridement of the wound and fasciotomy (Glass, 1976; 
Efrati, 1979), and involves the surgical removal of the 
tissue at the site of injection, based on the idea that 
most of the venom remains in the local area. Huang et al. 
(1974), treating 54 patients, claimed that by mechanically 
removing the tissue containing the injected venom, most of 
the venom can conceivably be eliminated, thereby reducing 
the magnitude of the systemic intoxication and local 
effects. Garfin et al (1984), however, in an experiment 
using subcutaneous injections of ~ ~ helleri venom in 
dogs, demonstrated that fasciotomy did not reduce the 
necrosis induced by the venom. In addition, muscle cells 
have been shown to regenerate following necrosis induced by 
taipoxin (Oxyuranus scutellatus), a myotoxin isolated from 
~ asper, and crude~ asper venom (Maltin et al., 1983; 
Gutierrez et al., 1984c). Surgical removal of muscle tissue 
during fasciotomy could possibly result in the removal of 
satellite cells responsible for regeneration. 
Steroids: Steroids have been used in conjunction with 
other treatments, based on their ability to reduce systemic 
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reactions (Stahnke and McBride, 1966; Glass, 1976). Reid 
et al. (1963), however, showed no improvement in response 
to ~ rhodostoma envenomation in a clinical study using 
prednisone. Schaeffer et al. (1979) also reported that 
corticosteroid analogs offered no benefical effects against 
~ ~ viridis venom shock. However, corticosteroids, 
antihistimines, and fluid infusion may prove helpful in 
treating systemic effects such as shock, anaphylaxis, and 
serum sickness (Schettler, 1954; Allam et al., 1956; 
McCollough and Gennaro, 1970; Schaeffer et al., 1978). 
Antivenoms: The use of antivenoms specific for 
individual snake venoms, or polyvalent antivenoms produced 
against a group of snake venoms, is by far the most 
utilized treatment for snake venom poisoning. Polyvalent 
and monovalent antivenoms are commercially available in 22 
countries and are produced against the venoms of 54 
different species (Minton, 1967). The use of antivenoms is 
based on the presence of specific, neutralizing antibodies 
directed against specific toxic components in the venom. 
In the United States, the most widely used polyvalent 
antivenom is Wyeth's Polyvalent (Crotalidae) Antivenom 
(Wyeth's Laboratories, Marietta, Pennsylvania), 
subsequently referred to as polyvalent antivenin, produced 
from horses inoculated with venoms from four snake species: 
~ atrox, ~ atrox, ~ adamanteus, and ~ ~ terrificus. 
These venoms were chosen because of the paraspecific 
protection against other venoms offered by the antivenom 
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due to common antigens in venoms (Criley, 1956; Minton, 
1976). Paraspecific protection by antivenoms for venoms 
not utilized in the antivenom production has been reported 
(Minton, 1967). Baxter and Gallichio (1974) demonstrated 
the ability of antivenom produced against Notechis scutatus 
to neutralize lethal effects of multiple sea snake species. 
Polyvalent antivenoms do not offer protection against all 
venoms from genera utilized in the inoculation, however. 
The Institute Clodomiro Picado in Costa Rica produces a 
polyvalent antivenom capable of offering protection against 
members of the genus Micrurus, with the exception of M. 
mipartitus, which is unaffected by the antiserum and 
requires an antivenom directed specifically against it 
(Bolanos et al., 1975). The use of a specific antiserum, 
however, requires that the snake inflicting the bite be 
identified. 
There have been several reports concerning the 
production of monovalent and polyvalent antisera, and the 
abilities of antisera to neutralize local and lethal 
effects induced by crude venoms and their toxic components. 
Ownby et al. (1979) successfully produced an antiserum in 
rabbits against purified myotoxin ~' isolated from ~ ~ 
viridis venom (OWnby et al., 1976). In a comprehensive 
study published as a series of reports, OWnby et al. tested 
the ability of the monovalent antiserum to myotoxin ~ to 
neutralize local and lethal effects of myotoxin ~' in vitro 
and in vivo, and crude ~ ~ viridis venom, in vitro (OWnby 
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et al., 1983a; Ownby et al., 1984). Also tested was the 
ability of a mixture of antiserum to myotoxin a and Wyeth's 
polyvalent antivenin to neutralize these same effects 
(Ownby et al., 1985; Ownby et al., 1986). The results 
showed that antimyotoxin ~ serum significantly neutralized 
a 0.75 mg/kg dose of myotoxin ~and a 1.5 mg/kg dose of 
crude venom, in vitro, as measured by the vacuolation 
index, which is a measure of the myotoxin a activity of the 
venom (Ownby, 1982). Neutralization of the higher dose of 
crude venom is explained by the fact that myotoxin a is 
only a fraction, 18% (Cameron and Tu, 1977), of the total 
crude venom protein. Polyvalent antivenin did not 
neutralize any of the mytoxin ~ activity of the crude venom 
tested. In vivo, antimyotoxin ~ serum significantly 
neutralized a 0.75 mg/kg dose of myotoxin ~if injected 
prior to toxin injection, and neutralization of a 0.38 
mg/kg dose if injected immediately afterwards. No 
protection was offered if antiserum injection was delayed 
fifteen minutes. A 1:1 mixture of antimyotoxin ~ serum and 
polyvalent antivenin significantly neutralized myonecrosis 
at a dose of 12.0 mg/kg crude venom, in vitro. The same 
mixture was able to neutralize a 1.5 mg/kg dose of crude 
venom if injected intravenously up to thirty minutes 
following in intramuscular injection of venom. These 
results demonstrate that toxin-specific antisera may prove 
useful in diminishing local effects resulting from snake 
venom poisoning, especially if used in conjunction with a 
polyvalent antiserum. Smith and Ownby (1985) showed that 
polyvalent antivenin significantly neutralized myonecrosis 
induced by a 6.0 mg/kg dose of ~ ~ horridus venom, in 
vitro. Ownby and Colberg (1986) reported the ability of 
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polyvalent antivenin to neutralize myonecrosis induced by a 
15.0 mg/kg dose of c. atrox venom. 
Polyvalent antivenin is much more effective in 
neutralizing hemorrhage and lethality induced by crude 
crotalid venoms. Ownby et al. (1984) showed that this 
antivenin could significantly neutralize hemorrhagic 
activity of a 24.0 mg/kg dose of ~ ~ viridis venom and 
that of a 12.0 mg/kg dose of ~ atrox venom, while Smith 
and Ownby (1985) reported neutralization of a 12.0 mg/kg 
dose of ~ ~ horridus venom. Ownby et al. (1983) reported 
neutralization of six times the Ln50 of ~ ~ viridis 
venom, though Criley (1956) reported neutralization of only 
2.21 times the Ln50 for this venom. Criley, however, used 
an i.v. injection route while Ownby et al. injected the 
venom i.m. It is interesting that Minton (1954) reported 
no significant neutralization of lethal effects by 
polyvalent antivenin induced by either ~ atrox or C. 
adamanteus venom, despite the fact that both venoms are 
used in the production of the antiserum. 
The ability of polyvalent antivenin to neutralize 
lethal effects is dependent on the time between venom 
deposition and antiserum administration. Russell et al. 
(1973) showed with~~ helleri venom that administration 
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of antivenin immediately after venom injection resulted in 
better protection against lethality than the delayed 
injection of antivenin. Minton (1954) reported that 50% of 
mice receiving antivenin fifteen minutes prior to an 
intraperitoneal injection of ~ ~ horridus venom survived, 
while only 35% survived if antivenin was delayed for 
fifteen minutes post-injection. 
Cross-Reactivity of Antigens: As previously 
mentioned, the use of polyvalent antivenoms is based on the 
paraspecific or cross-neutralization reactions offering 
protection against venoms other than those used in the 
inoculation (Criley, 1956; Minton, 1976). Rosenfeld and 
Kelen (1966) hypothesized that many snake species share 
common antigens in their venoms, especially within the same 
genus, and that cross-neutralization depended on the 
ability of antibodies to recognize common toxic antigens. 
Minton (1967) surveyed the paraspecific protection 
offered by elapid and sea snake antivenoms. The results 
showed that antivenoms raised against the Iran cobra (Naja 
naja oxiana), the tiger snake (Notechis scutatus), and the 
death adder (Acanthophis antarticus) were effective in 
neutralizing lethal effects of eight species of the genus 
Naja as well as members of the genera Enhydrina, Bungarus, 
and Micrurus. Even those antivenoms that failed to protect 
the animal against particular venoms prolonged survival 
time. Rosenfeld and Kelen (1966) looked at neutralization 
of coagulant activity in various genera of snakes, using 
45 
primarily antivenoms raised against Bothrops species. 
Their results showed extensive cross-neutralization by many 
monovalent antivenoms of venoms within the same genus, as 
well as neutralization of some species of a different 
genus. The polyvalent antivenom produced against venom 
from snakes of the Bothrops genus significantly neutralized 
the coagulant activity of all Bothrops species studied, in 
addition to offering some protection against venoms from 
the genus Crotalus. The most striking example of common 
antigens, or at least common antigenic sites, involved the 
use of a monoclonal antibody produced against a specific 
coelenterate lethal toxin. Russo et al. (1983) reported 
the detection of homologous antigenic sites on toxic 
proteins from c. d. terrificus, the hornet, Vespa 
orientalis, and the sea wasp, Chironex fleckeri. They also 
reported the use of an anti-Portugese man-of-war toxin 
antibody for the isolation of a toxin from ~ ~ terrificus 
venom. 
The use of monoclonal and monovalent antibodies 
against isolated toxin preparations for studying cross-
reactivity with other snake venoms and toxins has been 
reported. Rael et al. (1986) produced a monoclonal 
antibody to Mojave toxin, isolated from the venom of C. s. 
scutulatus, and used this antibody to detect common 
antigens with immunoblots of electrofocused crude venoms. 
Cross-reacting proteins were recognized in the venoms of c. 
basilicus, ~ ~ concolor, ~ ~ terrificus, and ~ ~ 
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durissus. Five bands, with isoelectric points ranging from 
5.1 to 6.1, were recognized in the venom of c. s. 
scutulatus. Kaiser et al (1986) demonstrated that 
antiserum raised against crotoxin, a potent neuro- and 
myotoxin in ~ ~ terrificus venom, successfully 
neutralized lethal activity of Mojave toxin (~ ~ 
scutulatus) and concolor toxin(~ v. concolor), both of 
which are also neurotoxins. These results indicate the 
possible utility of antisera raised against these 
neurotoxins in treatment of venom poisoning by snakes 
containing homologous neurotoxins. 
A primary objective of venom research is to develop 
better methods of treatment. The use of antisera mixtures, 
such as polyvalent antivenin and antimyotoxin a serum 
(Ownby et al., 1985; Ownby et al., 1986), and the inclusion 
of toxins or venoms known to cross-react with other venoms 
(Minton, 1967; Baxter and Gallichio, 1974; Rael et al., 
1986; Kaiser et al., 1986), may prove useful in the 
clinical snake bite treatment, hopefully reducing both 
lethal and local effects of poisoning. Other methods are 
also being pursued in attempts to improve antivenom 
effectiveness. Cross-linking the low molecular weight 
toxic fraction of the Malayan cobra, Naja naja sputatrix, 
with a neurotoxin isolated from the venom of the common sea 
snake, Enhydrina schistosa (Karlsson et al., 1972), with 1% 
glutaraldehyde prior to immunization in rabbits, Tan (1983) 
reported the production of an antivenom four to eight times 
more potent against lethal effects than the commercially 
used antiserum. Another method being utilized in attempts 
to improve antisera is affinity purification of specific 
antibodies and toxins (Lee and Chao, 1978; Lomonte et al., 
1985; Russell et al., 1985). 
Affinity Chromatogr~ 
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Affinity chromatography involves the separation of 
molecules based on biospecific interactions between the 
material being purified and the chromatographic column 
(Chaiken, 1983). Although this method is considered by 
some to include hydrophobic affinity, metal-ion affinity, 
as well as other interactions, most uses of affinity 
chromatography are based on biospecific interactions 
(Katchalski-Katzir, 1983). Column preparation requires the 
attachment of one member of the interacting pair to an 
insoluble matrix, such as sepharose, which is used to pack 
the column. The material containing the other member of 
the interacting pair is applied to the column. Any 
compound having an affinity for the solid phase matrix will 
bind, primarily through hydrophobic forces, electrostatic 
interactions, hydrogen bonding, and/or Van der Waals forces 
(Geld, 1973; Katchalski-Katzir, 1983), while all other 
materials pass through as the unbound material. The 
attached compound is then eluted by changing either the pH 
or ionic strength of the elution medium (Kennedy and 
Barnes, 1981; Sullivan and Russell, 1982; Bureau and 
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Daussant, 1983). This technique is relatively simple and 
allows the isolation of the material in a single step 
(Egarov, 1975). The purity of the isolate depends entirely 
on the purity of the material which is bound to the solid 
phase matrix. The types of interactions that have been 
exploited with this technique include antigen-antibody 
recognition (Lee and Chao, 1978; Sullivan and Russell, 
1982; Clegg and Smith, 1983), enzyme-inhibitor interactions 
(Cuatreca~as and Anfinsen, 1971; Schultz et al., 1983), 
hormone-carrier protein associations (Abercrombie et al., 
1983), and hydrophobic interactions (Boedeker and Cheney, 
1983; Werber et al., 1983). 
The major use of affinity chromatography in snake 
venom research has been in the purification of antibodies 
directed at either crude venoms or purified toxins. The 
purpose for this is two-fold. First, one of the serious 
drawbacks to polyvalent antivenoms, usually produced in 
horses against crude venoms, is the serum reactions many 
patients exhibit towards the foreign equine proteins in the 
antivenom, giving rise to anaphylactic and serum sickness 
reactions (McCollough and Gennaro, 1970; Sullivan and 
Russell, 1983). This problem is often compounded by the 
inability of the physician to determine the amount of 
antivenom required to neutralize the clinical symptoms of 
envenomation, leading to the administration of large 
amounts of antiserum (Russell et al., 1985). Second, the 
concentration of antibodies specific for a given toxin, one 
49 
that may be important in lethal or local effects, are often 
in very low concentrations in the polyvalent antivenom. 
Ownby et al. (1983b) demonstrated the very low titer of 
antibodies against myotoxin ~, a potent myotoxin from ~ v. 
viridis venom, with the enzyme-linked immunosorbent assay. 
The use of affinity chromatography allows not only the 
removal of excess serum proteins, most of which offer no 
protection against snake venom poisoning yet are very 
integral in serum reactions, but also allows for an 
increase in total concentration of the venom- or toxin-
specific antibodies, permitting the administration of more 
antiserum with a diminished likelihood of a serum reaction 
by the patient. 
Lee and Chao (1978) coupled Bungarus multicinctus 
venom to a cyanogen-bromide activated Sepharose 4b matrix. 
The crude horse antivenom specific for this venom was able 
to neutralize 0.76 Lo50 per milligram protein, injected 
subcutaneously in mice. The reconstituted lyophilyzed 
product following affinity chromatography neutralized 22.5 
LD50 per milligram protein, representing a 29.6-fold 
increase in neutralization capacity, clearly demonstrating 
an improvement in protection against the lethal effects of 
this venom. 
Cobrotoxin, isolated from the venom of Naja atra 
(Yang, 1965), is the main toxic component of this venom. 
Isolation of antibodies from the polyvalent antivenom 
produced against this toxin by gel filtration (Chang and 
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Yang, 1969) produced an antiserum that showed a 17.5-fold 
increase in neutralization capacity over the crude 
antiserum. However, affinity chromatography allowed the 
purification of an antibody fraction demonstrating a 23-
fold increase in neutralization capacity. Lomonte et al. 
(1985) purified antibodies against a myotoxin from B. asper 
venom (Gutierrez et al., 1984a) using this technique. The 
results showed the ability of the affinity-purified 
antibody to neutralize most of the myotoxic effects of the 
crude B. asper venom. The significance of these findings 
are two-fold. First, the increased neutralization capacity 
of affinity-purified antibodies is indicated. Second, the 
importance of individual venom components, in this case a 
myotoxin, in local reactions is clear. Ownby et al. (1985; 
1986) reported that a mixture of polyvalent (Crotalidae) 
antivenin and antimyotoxin ~ serum provided greater 
protection against myonecrosis induced by the crude venom 
than the polyvalent antivenin offered alone. The use of 
affinity-purified antibodies, in conjunction with other 
affinity-purified antibodies or polyvalent antivenoms, may 
prove successful in the clinical treatment of both lethal 
and local effects of snake venom poisoning. 
Affinity purification of antibodies from antisera does 
not always result in an increase in neutralization. Bober 
(1987) purified antibodies using affinity chromatography to 
myotoxin ~ from an antiserum produced in rabbits against 
this toxin (OWnby et al., 1979). The affinity-purified 
antibody was non-precipitating (as determined with 
immunodiffusion), nor did the antibody neutralize 
myonecrosis induced by the toxin at the amounts tested. 
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The affinity-purified antibody produced by Yang et al. 
(1977) against cobrotoxin was also non-precipitating, yet 
demonstrated a 23-fold increase in neutralization capacity 
of the lethal effects over the crude antiserum. The 
inability of the purified antibody produced by Bober (1987) 
to neutralize myonecrosis may be due to the inability of 
the antibody to recognize the antigenic site or sites 
associated with the induction of necrosis or to the 
relatively low amounts of antibody tested. 
The use of purified toxins and affinity-purified 
antibodies have other uses in snake venom research. The 
detection of particular toxins in different species of 
snakes has been discussed. By determining the prevalence 
of a toxin in a group of snakes, and depending on the 
importance of the toxin in the local and lethal effects of 
venom poisoning, more effective antisera may be produced by 
selecting venoms containing the particular toxin. The use 
of mixtures of antisera in the treatment of snake venom 
poisoning has also been indicated. Another use of purified 
toxins and antibodies involves the localization of the 
toxin in the tissue with immunohistochemical techniques, 
perhaps offering some insight into the mechanism of action 
of the toxin. 
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Immunohistochemistry 
The location of proteins within tissues can be 
determined with the techniques of immunohistochemistry and 
immunocytochemistry, techniques which are predicated on the 
specificity of antigen-antibody interactions (Griffith, 
1982). The term immunohistochemistry is used for 
visualization at the light microscopic level, while 
immunocytochemistry is used for the electron microscopic 
level, though the terms are often used interchangeably. 
The basic steps of these techniques are as follows: (1) 
the tissue containing the protein to be localized is either 
chemically fixed with a cross-linking molecule, such as 
glutaraldehyde or formaldehyde, or rapid-frozen in an 
appropriate solvent, such as isopentane or acetone; (2) the 
tissue is embedded in a resin (unless frozen) and 
sectioned; (3) a specific monovalent, monoclonal or 
affinity-purified antibody, referred to as the primary 
antibody, produced against the protein to be localized is 
applied to the tissue; (4) a secondary antibody conjugated 
to a specific label, such as fluorescein, produced against 
the primary antibody is applied to the tissue; (5) the 
section is treated so that the label is visable, for 
example, with ultraviolet light if fluorescein is the 
label. The major difference between the two techniques, 
besides the method of viewing the tissue, occurs at the 
labelling process. For immunohistochemistry, the label 
must be visible with the light microscope, while, for the 
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electron microscope and immunocytochemistry, the label must 
be electron dense and capable of withstanding the energy of 
the electron beam. Also, there are multiple variations on 
these techniques relative to the labels used. For example, 
the label may be the result of an enzymatic reaction which 
forms an insoluble precipitate at the site of the antigen. 
This is the basis of the peroxidase-antiperoxidase 
technique (Mohanty, 1982). The use of protein A conjugated 
to colloidal gold has also been used at both the light and 
electron microscope levels (Holgate et al., 1983). This 
techique is based on the fact that protein A binds the Fe 
portion of the IgG primary antibody, eliminating the 
secondary antibody. Fluorescein and rhodamine are used as 
labels due to their easy viewing following excitation 
(Williamson et al., 1980; Dongen et al., 1985). 
Immunohistochemistry has been used to localize proteases in 
murine skeletal muscle. Stauber et al. (1985) used 
flourescent labeled antibodies in the localization of 
cathepsin proteases in frozen thick sections of muscle. 
There are only two reports in the literature 
concerning the localization of snake venoms or their 
components in mammalian tissues. Schiff et al. (1984) 
described the localization of c. atrox venom in pulmonary 
tissue of mice following "in vivo envenomation," an 
intraperitoneal injection of a 10 mg/kg dose. The tissue 
was processed one hour following the injection. 
Horseradish peroxidase (HRP) was conjugated to Wyeth's 
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polyvalent (Crotalidae) antivenin and used as the antigen-
specific antiserum. No secondary antibody was required. 
The results of this study were as follows: (1) the 
reaction product was found on the alveolar surface of type 
I and II cells, in cytosomes of type II cells, and in 
membrane bound vesicles of type I cells; (2) macrophages in 
the area contained large quantities of the reaction 
product; and (3) no reaction product was found on or in 
endothelial cells, or in the surrounding connective tissues 
spaces. Although no reaction product was seen in or around 
endothelial cells, the authors proposed that the venom 
components were carried across the blood-air barrier where 
they came to lie at the air/surfactant interface. This 
conclusion was based on the presence of membrane-bound 
vesicles, although these were seen only in type I cells, 
and only rarely in these cases. The authors offered no 
evidence to explain how the venom crossed the endothelial 
cell or the connective tissue septum. The authors also 
proposed that there was affinity for the 
phophatidylcholine-rich surfactant by the phospholipase in 
the venom, explaining the location of the reaction product 
and the association with the type II cells. 
Tu and Morita (1983) reported the localization of 
myotoxin ~, isolated from the venom of ~ ~ viridis, in 
vitro, using myotoxin ~ conjugated directly to HRP. No 
immunoglobulins were utilized. Human biopsy samples were 
frozen and sectioned at 10-20 microns in thickness. The 
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myotoxin a-HRP conjugate was applied directly to the 
tissue. After washing and treatment with the peroxidase 
substrate, the sections were embedded in plastic and 
prepared for the electron microscope. The results 
demonstrated binding of the myotoxin ~-HRP conjugate only 
to the sarcoplasmic reticulum and occasionally in the 
cisternae of this organelle. No reaction product was 
observed at the sarcolemma or in association with other 
cellular organelles. Because myotoxin ~ causes severe 
vacuolation of the sarcoplasmic reticulum (OWnby et al., 
1976), Morita and Tu concluded that myotoxin ~induces 
myonecrosis through a possible interaction with the calcium 
regulatory function associated with the sarcoplasmic 
reticulum. 
CHAPTER III 
ISOLATION OF HEMORRHAGIC TOXIN B 
FROM CROTALUS ATROX VENOM 
Introduction 
Hemorrhagic toxin b (HTb) is only one of many 
hemor~hagic toxins found in Crotalus atrox venom. In 1978, 
Bjarnason and Tu reported the isolation of five hemorrhagic 
components from ~ atrox venom. Since that time, two 
additonal hemorrhagic toxins have been isolated (Nikai et 
al., 1984; Nikai et al., 1985). All seven hemorrhagic 
toxins from c. atrox are described as metalloproteases with 
zinc being the necessary metal ion. Removal of the zinc 
ion with metal chelators, such as EDTA and ortho-
phenanthroline, destroys both the proteolytic activities 
and hemorrhagic activities of all the toxins (Ownby et al., 
1975; Bjarnason and Tu, 1978). 
The pathogenesis of hemorrhage induced by snake venoms 
and their components can be of two types, per rhexis or per 
diapedesis (Ohsaka et al., 1971; Ownby et al., 1974). In 
hemorrhage per diapedesis, such as is seen with the 
hemorrhagic principle HR-1 from the venom of Trimeresurus 
flavoviridis, erythrocytes are described as exiting the 
vascular compartment through gaps in intercellular 
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junctions in the absence of endothelial cell lysis (Ohsaka 
et al., 1971; Tsuchiya et al., 1974). Since the hemorrhagic 
components from T. flavoviridis are able to cause the 
release of proteins and carbohydrates from the isolated 
glomerular basement membrane preparation, the hemorrhage 
that results from the action of the hemorrhagic principles 
is presumed to be due to the lysis of the underlying 
basement membrane of endothelial cells, resulting in a 
weakening of the intercellular junctions and escape of 
erythrocytes (Ohsaka et al., 1973). In contrast, 
hemorrhage per rhexis is described as the escape of 
erythrocytes through damaged endothelial cells rather than 
through compromised intercellular junctions. This type of 
hemorrhage is found with c. atrox venom (Ownby et al., 
1974) and with the purified hemorrhagic toxins a, b and e 
from this venom (Ownby et al., 1978). Hemorrhagic toxin b, 
however, demonstrates an unusual hemorrhagic pattern. 
Unlike many other toxins, including the other toxins from 
~ atrox, hemorrhage does not ensue until after a latent 
period of at least 20 min after initial injection of the 
toxin (Smith et al., unpublished results). 
HTb has also been described as a myotoxin, causing 
myonecrosis in addition to hemorrhage (Ownby et al., 1978). 
It is unclear, however, whether the toxin is directly 
myotoxic, causing necrosis due to a direct lytic action of 
the toxin on the muscle cells, or if the myotoxicity is of 
an indirect origin, resulting from the ischemic conditions 
induced by the hemorrhage. Ownby et al. (1978) described 
the presence of intact capillaries next to necrotic muscle 
cells using electron microscopy techniques, indicating a 
possible direct myotoxic effect of the toxin. 
Further study of the pathogenesis of hemorrhage and 
myonecrosis caused by HTb requires a purified protein 
preparation. The present chapter describes the isolation 
of HTb and some biochemical properties of both the toxin 
and fractions obtained from c. atrox venom. 
Materials and Methods 
Venom 
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Lyophilized ~ atrox venom was purchased from Dr. John 
Perez. The venom was collected from adult specimens 
captured around Sweetwater, Texas at the Big Spring 
Rattlesnake Roundup in 1983 and was pooled, lyophilized, 
and stored at -20°C until use. Before beginning the 
purification, 2.0 gm of venom was dissolved in 50 ml of 
0.01 M Tris-Cl buffer, pH 8.6 and centrifuged at 40,060 g 
in a Sorvall SM-24 rotor (Dupont Co., Newtown, CN) for one 
hour to remove particulate matter. The supernatant was 
desalted in an Amicon Model 400 ultrafiltration cell 
(Amicon Corp., Danvers, MA) equipped with a YM-10 membrane 
(exclusion limit - 10,000 daltons) and was subsequently 
concentrated to 5.0 ml in an Amicon Model 50 
ultrafiltration cell equipped with a YM-10 membrane. 
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Isolation of Hemorrhagic Toxin ~ 
Figure 1 is a flow diagram of the steps used in the 
isolation of HTb. The selection of fractions to be further 
chromatographed was based on the presence of hemorrhagic 
and proteolytic activity. Protein concentration was 
monitored by the absorbance at 280 nm. The concentrated, 
desalted venom sample was applied to a 2.6 X 27 em column 
of DEAE-Sephacel (Pharmacia Fine Chemicals, Piscataway, NJ) 
equilibrated with 0.01 M Tris-Cl buffer, pH 8.6. Elution 
with the equilibration buffer was continued until the 
unbound material had eluted, at which time a 2000 ml linear 
gradient of 0.0 M to 0.25 M NaCl in 0.01 M Tris-Cl, pH 8.6, 
was started. A flow rate of 30 ml/hr was maintained by a 
peristaltic pump. Fractions of 8.2 ml were collected until 
elution of the unbound material, after which fractions of 
19.0 ml were collected. The unbound material was 
collected, pooled and concentrated to 5.0 ml in an Amicon 
ultrafiltration cell over a YM-10 membrane. The 
concentrated fractions from the ion-exchange were applied 
to a 2.6 X 85 em column of Ultrogel AcA 54 (LKB Corp., 
Rockville, MD) equilibrated in 0.01 M TAPS-Cl buffer, 0.15 
M NaCl, pH 8.6. A flow rate of 30 ml/hr was maintained by 
a peristaltic pump and fractions of 6.0 ml were collected. 
The second major absorbance peak was collected and pooled. 
Buffer exchange into 0.01 M TAPS-Cl, pH 8.6, was performed 
by dialfiltration in an Amicon Model 400 ultrafiltration 
cell equipped with a YM-10 membrane, followed by 
Figure 1. Isolation procedure used in the purification of 
hemorrhagic toxin b. 
ISOLATION PROCEDURE 
CRUDE VENOM SOLUTION 
DESALTING AND CENTRIFUGATION 
• (supernatant) 
ANION EXCHANGE ON DEAE-SEPHACEL 
(0.01 M Tris-Cl, pH 8.6, 0-0.25 M NaCl) 
• (fraction A1) 
GEL FILTRATION ON LKB ULTROGEL ACA 54 
(0.01 M Na-MOPS, pH 8.6, 0.15 M NaCl) 
• (fraction B2) 
CATION EXCHANGE ON CM-FRACTOGEL 
(0.01 M Na-MOPS, pH 8.6, 0-0.15 M NaCl) 
• (fraction C6) 
HYDROPHOBIC INTERACTION ON PHENYL-SEPHAROSE CL-4B 
(0.01 M Tris-Cl, pH 7.2, 1.5-0 M Ammonium Sulfate, 
0-50% Ethylene Glycol) 
• 
PURIFIED HTb 
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concentration to approximately 5.0 ml. The concentrated 
fractions from the gel filtration separation were applied 
to a 1.6 X 33 em column of Fractogel TSK CM-6508 cation 
exchanger (EM Sciences, Gibbstown, NJ) equlibrated with 
0.01 M TAPS-Cl, pH 8.6. The column was eluted with a 750 
ml linear gradient of 0.0 M to 0.15 M NaCl in 0.01 M TAPS-
Cl immediately after sample loading. The flow rate was 30 
ml/hr and 6.0 ml were collected. The sixth major 
absorbance peak was collected and pooled. A buffer 
exchange into 0.01 M Tris-Cl buffer, 1.5 M ammonium 
sulfate, pH 7.2, was performed using an Amicon Model 400 
ultrafiltration cell equipped with a YM-10 membrane . The 
sample was concentrated to 5.0 ml and applied to a 1.6 X 27 
em column of Phenyl-Sepharose CL-4B (Pharmacia Fine 
Chemicals) hydrophobic interaction column equilibrated with 
0.01 M Tris-Cl, pH 8.6. The column was eluted with a 600 
ml linear gradient immediately after sample application. 
The composition of the starting buffer for the gradient was 
1.5 M ammonium sulfate, 0.01 M Tris-Cl, pH 7.2 and the 
limit buffer was 0.01 M Tris-Cl, pH 7.2, containing 50% 
ethylene glycol. The flow rate was 25 ml/hr and 6.0 ml 
fractions were collected. One broad peak eluted and 
collected, pooled, concentrated into 0.01 M Na-MOPS buffer, 
0.01 M NaCl, pH 7.2, and stored at 20°C until use. 
The concentration of HTb was determined by dividing 
the absorbance at 280 nm by a molar extinction coefficient 
with a value of 1.2756. This value was calculated using 
the amino acid composition reported by Bjarnason and Tu 
(1978) which included four tryptophan and seven tyrosine 
residues. 
Electrophoresis 
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The purified HTb was analyzed using SDS-polyacrylamide 
slab gel electrophoresis (SDS PAGE) according to the method 
of Laemmli (1970) under conditions of complete denaturation 
and reduction. The resolving gel was 10% total acrylamide 
with 2.7% bisacrylamide. The stacking gel was 4% total 
acrylamide with 2.7% bisacrylamide. The following 
molecular weight standards, purchased from Sigma Chemicals, 
were used: myosin (205,000 Da), beta-galactosidase 
(116,000 Da), phosphorylase b (97,000 Da), bovine serum 
albumin (66,000 Da), egg albumin (45,000 Da), 
glyceraldehyde (36,000 Da), carbonic anhydrase (29,000 Da), 
trypsinogen (24,000 Da), trypsin inhibitor (20,100 Da), and 
alpha-lactalbumin (14,200 Da). A sample of the purified 
HTb containing 0.10 mg of protein was combined with an 
equal volume of sample buffer, 0.125 M Tris-Cl, 4% SDS, 2% 
sucrose, and 10% 2-mercaptoethanol, pH 6.8, and heated at 
100°C for 3.0 min. The sample was electrophoresed at 35 rnA 
for approximately 2 hr in a LKB (Rockville, MD) 
electrophoresis unit cooled to 15°c. The gel was fixed in 
3.46% sulphosalicylic acid containing 11.5% trichloracetic 
acid for several hours. Following fixation, the gel was 
washed for 20 min in destaining solution consisting of 25% 
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ethanol and 4% acetic acid. The gel was then stained 
overnight in 1% Coomassie blue R-250. Destaining was 
carried out until the gel became clear. 
Enzyme Assays 
Protease activity was measured according to the method 
of Lin et al. (1969) using N,N-dimethylcasein as the 
substrate. The following reagents were necessary for the 
assay: (1) 0.1% N,N-dimethylcasein (Sigma Chemical Co.); 
(2) 0.1% trinitrobenzene sulfonic acid (TNBS, Sigma 
Chemical Co.); (3) 4.0% sodium bicarbonate; (4) 10% SDS; 
and (5) 1.0 N HCl. A 0.02 mg sample from every third 
fraction of all columns was incubated with 1.0 ml of the 
dimethylcasein in 0.005 M Na-MOPS at 38°C for 30 min at a 
pH of 7.2. The enzymatic reaction was stopped by immersing 
the solution in a boiling water bath for 1.0 min. Added to 
the sample solution was 1.0 ml TNBS and 1.0 ml sodium 
bicarbonate. This solution was incubated for 30 min at 
50°c in the dark. The reaction was stopped by the addition 
of 1.0 ml SDS and 0.5 ml HCl. The absorbance at 340 nm was 
read. The number of free amino terminals was determined by 
dividing the A340nm by the extinction coefficient 1.3 x 104 
-1 
moles em. One unit is defined as one mole of peptide 
bonds cleaved during the thirty minute incubation period. 
The protease activity of the fractions following 
hydrophobic interaction chromatography was not determined 
since the ammonium sulfate interferred with the TNBS 
reaction. The protease activity of the pooled fraction 
after buffer exchange, however, was determined. 
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Arginine esterase activity was determined according to 
the method of Rick (1963) using benzoylarginine ethyl ester 
(BAEE, Sigma Chemical Co.) as the substrate. The substrate 
solution consisted of a 3.43% BAEE in 0.05 M Tris-Cl, pH 
8.0, containing 0.222% cac12 . The procedure consisted of 
adding 0.1 ml of every third fraction from anion exchange 
chromatography to 1.0 ml of the substrate solution and 
monitoring the change in absorbance at 254 nm, recording 
the change every 30 sec for 4.0 min. The micromoles 
substrate hydrolyzed per minute was calculated by dividing 
the change in A254/min by 1.046. One unit is defined as 
one mole of BAEE hydrolyzed per minute. 
Phospholipase activity was determined according to a 
modification on the method of Bon and Saliou (1983) as 
follows. The following solutions were used in the assay: 
(1) lecithin solution: 1.0 gm lecithin (Sigma Chemicals) 
was dissolved in 10 ml methanol and 3.0 Tween 20, filtered 
and brought to 20 ml with distilled water; (2) indicator 
solution: 6.0 mg cresol red (Sigma Chemicals) was 
dissolved in 1.0 ml methanol and brought to 100 ml with 
distilled water; (3) buffer substrate solution: 4.0 ml of 
the lecithin solution was mixed with 7.0 ml of indicator 
solution, 3.0 ml of 0.1 M glycylglycine solution, 1.0 ml 90 
mM cac12 solution and brought to 30 ml with distilled 
water. The pH was adjusted to 9.5 with 2.0 N NaOH. The 
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assay consisted of adding 0.01 ml of every third tube from 
anion exchange chromatography to 1.0 ml of the buffer 
substrate solution and reading the change in absorbance at 
578 nm, recording the value at 30 sec intervals. The 
extinction coefficient used in the calculation of activity 
was determined by adding 0.03 ml of a 0.1 N HCl solution to 
3.0 ml of the buffer substrate solution. The absorbance at 
578 nm of the buffer substrate solution after addition of 
the acid was subtracted from the absorbance of the solution 
prior to acid addition. The difference was used in the 
calculation. The volume activity was determined by the 
following equation: 
Vol. act= [(1.01) x (Change in A578/min)] 
(extinct. coeff.) x (1.0) x (0.01) 
The activity was recorded as units/ml sample. One unit is 
-3 defined as a change of 2.42 X 10 absorbance units per 
minute. 
Hemorrhage 
The maintenance of hemorrhagic activity was monitored 
following each chromatographic step by injection of 0.05 ml 
of the pooled sample into the thigh of a mouse. After 
three hours, the mouse was killed and the skin removed to 
evaluate the presence or absence of hemorrhage. 
Chromatofocusing 
A Pharmacia 2.6 X 30 em column of polybuffer exchanger 
118 was equilibrated with triethanolamine buffer, pH 10.5 
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and eluted with polybuffer exchanger 118, pH 8-10.5 buffer. 
A sample of 25 mg of HTb dissolved in the triethanolamine 
buffer, pH 10.5, was applied to the column and a flow rate 
of 20 ml/hr was maintained with a peristaltic pump. 
Fraction sizes of 6.0 ml were collected .and the absorbance 
at 280 nm recorded. 
PH Optimum 
The pH optimum of the protease activity of the 
partially purified toxin (following cation exchange 
chromatography) was determined by performing the protease 
assay described previously, but preparing the 
dimethylcasein in 0.005 M Na-MOPS buffer titrated to the 
following pH values: 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 
9.5, 10.0, 10.5, and 11.0. 
Results 
Isolation 
Figure 2 is the elution profile obtained for crude c. 
atrox with anion exchange chromatography. Nine major 
fractions were obtained, and all contained protease 
activity with fraction A1 having the largest activity. 
Only fractions A2, A4, AS, and A6 had arginine esterase 
activity while only fraction A6 had phospholipase A2 
activity. Because HTb is a basic protein, only fraction 
A1, tubes 7 through 25, which also demonstrated hemorrhagic 
activity, was collected, pooled, and concentrated for gel 
Figure 2. Fractionation of 2 gm crude c. atrox venom on 
DEAE-Sephacel. The column-was eluted with 
equilibration buffer, 0.01 M Tris-Cl, pH 8.6, 
until elution of the unbound material, 
followed by a 2000 ml linear gradient of 0.0 M 
- 0.25 M NaCl at a flow rate of 30 ml/hr. 
Peak one, tubes 7 - 25, was pooled and 
concentrated for further purification. 
Fractions of 8.2 ml were collected during the 
elution of the unbound fraction, and increased 
to 19.0 for the remainder of the 
separation.Figure 2. Column size: 2.6 X 27 
em. 
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filtration chromatography. 
Figure 3 is the elution profile obtained from the 
separation of fraction Al with gel filtration. Two major 
fractions were obtained with a very minor third fraction. 
Only fractions B1 and B2 had protease activity, and only 
fraction B2 was hemorrhagic. Esterase and phospholipase 
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activities were not measured after anion exchange 
chromatography since these activities were not observed in 
the unbound fraction, A1. Fraction B2, tubes 53 through 
64, was collected, pooled, and concentrated for application 
to cation exchange chromatography. 
Figure 4 is the elution profile of the separation of 
fraction B2 on cation exchange chromatography. Six 
fractions were obtained with only fraction CS and C6 having 
protease activity. Fraction CS had the greatest protease 
activity, but was only slightly hemorrhagic. Fraction C6, 
tubes 91 through 100, however, was very hemorrhagic and was 
therefore collected, pooled, concentrated, and applied to 
the hydrophobic interaction column. 
Figure 5 is the elution profile obtained with 
hydrophobic interaction chromatography. One broad peak, 
eluted which was collected, concentrated an exchanged into 
a 0.01 M Na-MOPS buffer containing 0.01 M NaCl, pH 7.2, and 
stored frozen until use. The pooled protein, tubes 31 
through 62, contained protease activity measuring 1.57 
mU/ml. 
Figure 6A shows the homogeneity of the purified HTb 
Figure 3. Gel filtration of fraction A1 from anion 
exchange chromatography on LKB AcA 54, 
equilibrated with 0.01 M Na-MOPS, 0.15 M NaCl, 
pH 8.6. A flow rate of 30 ml/hr was applied. 
Peak two, tubes 53 - 64, was pooled and 
concentrated for cation exchange 
chromatography. Fractions of 6.0 ml were 
collected. Column size: 2.6 X 85 em. 
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Figure 4. Fractionation of fraction B2 from gel filtration 
chromatography on Fractogel TSK 650S cation 
exchanger, equilibrated with 0.01 M TAPS-Cl, 
pH 8.6. A 750 ml linear gradient of 0.0 M -
0.15 M NaCl was applied at a flow rate of 30 
ml/hr immediately after sample loading. Peak 
six, tubes 91 - 100, was pooled and 
concentrated for hydrophobic interaction 
chromatography. Fractions of 6.0 ml were 
collected. Column size: 1.6 X 33 em. 
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Figure 5. Fractionation of fraction C6 from cation 
exchange chromatography on Phenyl-Sepharose 
CL-4B, equilibrated with 0.01 M Tris-Cl, 1.5 M 
ammonium sulfate, pH 7.2. A 600 ml linear 
gradient of decreasing ammonium sulfate, 1.5 M 
- 0.0 M, concentration and increasing ethylene 
glycol, 0% - 50%, was applied at a flow rate 
of 25 ml/hr. A single broad peak was 
collected, tubes 31 ~ 62, subjected to a 
buffer exchange, and stored at -20°c until 
use. Fractions of 6.0 ml were collected. 
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using a 10% SDS polyacrylamide gel electrophoresis. In 
lane 1 were the molecular weight standards, excluding 
myosin. In lane 2 was HTb at 0.005 mg/well, and in lane 3 
was HTb at 0.01 mg/well. Only one band was visible, 
demonstrating a homogeneous protein. The HTb protein band 
migrated slightly farther than the trypsinogen standard, 
which has a molecular weight of 24,000 daltons, indicating 
that HTb had a molecular weight of approximately 23,000 
daltons. Bjarnason and Tu (1978) reported a molecular 
weight of 24,000 daltons by SDS disc gel electrophoresis 
and 19,000 daltons by gel filtration. Figure 6B is a 
photograph of the SDS-polyacrylamide gel of the protein 
following the cation exchange chromatography which shows a 
second lower molecular weight contaminating band. The 
molecular weight standards were the same as those described 
above. Lanes 2 and 3 also contained 0.005 and 0.01 mg/well 
respectively. 
A total of 68.46 mg of purified toxin was recovered 
from the isolation procedure described above. This 
represents at least 3.42% of the crude venom. Bjarnason 
and Tu (1978) reported a value of 3.70%. 
The hemorrhagic activity of the toxin was maintained 
throughout the isolation procedure until the final 
hydrophobic interaction chromatographic step. During this 
chromatographic procedure, the hemorrhagic activity of the 
venom was destroyed even though the toxin was still 
proteolytic. However, this step was necessary to produce a 
Figure 6A. 10% SDS-polyacrylamide slab gel demonstrating 
the single, homogeneous band of HTb following 
hydrophobic interaction chromatography. Lane 
1: molecular weight standards (beta-
galactosidase, 116,000 Da; phosphorylase b, 
97,000 Da; bovine serum albumin, 66,000 Da; 
egg albumin, 45,000 Da; glyceraldehyde, 
36,000 Da; carbonic anhydrase, 29,000 Da; 
trypsinogen, 24,000 Da; trypsin inhibitor, 
20,100 Da; and alpha-lactalbumin, 14,200 Da); 
lane 2: HTb at 0.005 mg/well; lane 3: HTb at 
0.01 mg/well. 
Figure 6B. 10% SDS-polyacrylamide slab gel demonstrating 
the lack of homogeneity of the protein 
following cation exchange chromatography. 
Lane 1: same molecular weight standards 
described for Figure 5; lane 2: 0.005 
mg/well; lane 3: 0.01 mg/well. 
+ 
1 2 3 
+ 
1 . 2 3 
----... .. __ 
purified toxin required in immunization for antibody 
production, since the fraction following cation exchange 
chromatography contained more than a single protein. 
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During the chromatofocusing procedure, if the 
isoelectric point of the toxin was less than 10.5 pH units, 
the protein would have bound to the column. However, the 
HTb did not bind at all, eluting with the unbound fraction. 
This demonstrates that the isoelectric point of HTb must be 
greater than 10.5. 
The results of the pH optimum experiment are shown in 
Figure 7. The values are graphed as the absorbance at 340 
nm according to the procedure described for the protease 
assay in Materials and Methods. The protein had a very 
broad pH range, over which it maintained the ability to 
hydrolyze dimethylcasein. 
Discussion 
Hemorrhagic toxin b has been isolated to homogeneity 
as evidenced by SDS PAGE. It has a molecular weight of 
approximately 23,000 daltons and an isoelectric point 
greater than 10.5. It possesses proteolytic activity with 
dimethylcasein as a substrate, and is devoid of both 
esterase and phospholipase activity with BAEE and egg yolk 
lecithin as substrates, respectively. It represents 
approximately a minimum of 3.4% of the crude venom protein. 
Bjarnason and Tu (1978) reported the isolation of HTb 
to homogeneity as measured by SDS disc gel electrophoresis 
Figure 7. Determination of the pH optimum of the 
proteolytic activity of HTb on dimethylcasein. 
Htb used was fraction C6 following cation 
exchange chromatography. Values are plotted 
as absorbance at 340 nm according to the 
protease assay method of Lin et al. (1969) as 
described in Materials and Method. Twenty 
microliter samples of fraction C6 were 
incubated for thirty minutes with the 
substrate (0.1% dimethylcasein) in 0.01 M Na-
MOPS buffer adjusted to pH values ranging from 
6.0 to 11.0. 
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using the following isolation procedure: fractionation on 
a Whatman DE 32 anion exchange column; fractionation on a 
Sephadex G-75 superfine; fractionation on a Whatman CM 32 
cation exchange resin; a second fractionation on the cation 
exchange column. In the present study, an additional 
method of purification, hydrophobic interaction 
chromatography on phenyl sepharose CL-4B, was required to 
yield a homogeneous protein, since the isolate following 
cation exchange chromatography demonstrated contaminants 
(Figure Sb). A possible reason for the additional 
purification step requirement as presented here could be 
due to a difference in the venoms. Glenn and Straight 
(1978) reported variations in toxicity of the venoms from 
~ scutulatus scutulatus specimens collected from different 
geographic regions in the United States and Mexico. Minton 
and Weinstein (1986) also reported differences in 
proteolytic and lethal activities of venoms from ~ atrox 
collected from various geographic areas. These reports 
demonstrate that venom compositions can vary depending on 
their origin, and may explain the difference in the 
isolation protocol used by Bjarnason and Tu (1978) and that 
reported here. Also, Bjarnason and Tu (1978) reported that 
HTb represented 3.7% of the crude venom protein, while the 
results presented here demonstrate that HTb is only 3.46% 
of the protein. This difference could be due to three 
possible reasons: (1) variations in the venoms; (2) the 
conditions, such as which tubes should be collected and 
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concentrated for a given elution peak or fraction, used in 
pooling the protein fractions following each 
chromatographic step; or (3) the the removal in the present 
study of contaminating proteins present in the "purified" 
HTb reported by Bjarnason and Tu (1978). The possibility 
of a combination of these factors should also be 
considered. 
The inability of the toxin to bind the 
chromatofocusing column equilibrated with a buffer at a pH 
of 10.5 indicates the toxin has an isoelectric point 
greater than 10.5. This is considerably more basic than 
any other hemorrhagic toxin reported in the literature, 
although AaHIII, from the venom of Agkistrodon acutus, has 
a reported pi greater than 9.0. There are several 
myotoxins that have reported isoelectric points greater 
than 9.8. Some of these are peptide C, from the venom of 
c. viridis helleri (Maeda et al, 1978), myotoxins I and II, 
from the venom of~~ concolor (Engle et al., 1983), and 
mulgotoxin A, from the venom of Pseudechis australis 
(Leonardi et al .. 1979). The basicity of HTb may be 
important in the mechanism of action leading to hemorrhage 
and/or myonecrosis. However, mucrotoxin A, from the venom 
of ~ flavoviridis, is also a hemorrhagic myotoxin, but 
with a pi of 4.3, indicating that both basic and acidic 
toxins can induce hemorrhage and myonecrosis. 
A question that has been raised by reports in the 
literature concerns the relationship between proteolytic 
85 
activity and hemorrhagic activity of hemorrhagic toxins. 
It is interesting that Civello et al. (1983a) make the 
statement " •.. very few of the hemorrhagins have been shown 
to contain proteolytic activity," because a review of the 
literature has shown that all of the hemorrhagic toxins 
thus far isolated have proteolytic activity on either 
casein ur hide powder azure, with the notable exceptions of 
HR-1, HR-2a, and HR-2b, toxins isolated from the venom of 
~ flavoviridis (Takahashi and Ohsaka, 1970; Ohsaka et al., 
1973). These venoms, however, do cause the release of 
proteins from the glomerular basement membrane preparation. 
Bjarnason and Tu (1978) did, however, demonstrate a lack of 
direct relationship between proteolytic activity and 
hemorrhagic activity of five of the hemorrhagic toxins 
present in the venom of c. atrox. HTa, for example, was 
the most hemorrhagic of the toxins, yet it had the least 
activity on casein. The presence or absence of proteolytic 
activity, or the degree of activity on a given substrate, 
depends to a large degree on the particular substrate used 
in the assay (Bjarnason and Tu, 1978). Because a protein 
lacks proteolytic activity on a given substrate does not 
necessarily mean the protein is not a protease. Given the 
right substrate, many toxins previously described as being 
non-proteolytic may very well be proteolytic. HTb, which 
has been described as a specific protease (Bjarnason and 
Tu, 1978), is able to hydrolyze insulin B chain and 
glucagon (Hagihara et al., 1985), casein (Bjarnason and Tu, 
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1978), and fibrinogen (Komori et a1., 1985). Fox et al. 
(1983) propose that the disruption of the basal lamina by 
proteases in the venom would be an important mechanism in 
the hemorrhagic response. Obviously, the disruption of the 
basal lamina could be facilitated by the presence of a 
protease capable of hydrolyzing proteins that are a part of 
this structure. The hemorrhagic toxin HP IV, isolated from 
the venom of c. horridus horridus (Civello et al., 1983a), 
which has no collagenase activity (Civello et al., 1983b), 
is capable of disrupting the basal lamina (Ownby and Geren, 
in press), despite the fact that the major protein of the 
basal lamina is collagen. Treating the purified 
hemorrhagic toxins from ~ atrox venom with EDTA, Bjarnason 
and Tu (1978) demonstrated the complete loss of hemorrhagic 
activity concomitant with loss of proteolytic activity. 
The same results were reported by Friederich and Tu (1971) 
using crude venoms from the genera Agkistrodon, Crotalus, 
Sisturus, Vipera, and Bothrops. These results clearly 
demonstrate at the least a relationship between the two 
activities. However, in the present study, it was noted 
that application of the partially purified HTb to the 
hydrophobic interaction column resulted in a loss of 
hemorrhagic activity when tested i.m. in mice, yet without 
loss of proteolytic activity on dimethlycasein. 
Application of the protein to this column, which was eluted 
with a decreasing linear gradient of 1.5 M ammonium sulfate 
and increasing ethylene glycol, was necessary to acheive 
87 
the purity required for immunization. Obviously, 
proteolytic activity can be retained even with the loss of 
hemorrhagic activity. This is not surprising since there 
are a number of proteolytic toxins, such as the proteases 
I, II, III, and IV, from the venom of C. atrox, that do not 
induce hemorrhage. The loss of hemorrhagic activity with 
elution from the hydrophobic interaction column could 
possibly be due to a conformational change resulting from 
the following: (1) interaction with the phenyl-sepharose 
matrix; (2) the high ionic strength of the ammonium sulfate 
which was required for the toxin-matrix binding 
interaction; or (3) the presence of the ethylene glycol, 
which was included to facilitate hydrophilicity of the 
toxin and a more efficient purification step. A 
combination of these effects could also be possible. 
Further work considering these factors could help elucidate 
the mechanism of action of HTb, especially related to it's 
proteolytic activity. It is possible that there are two 
regions on the molecule involved in the hemorrhagic 
response in vivo, one region responsible for the binding of 
the toxin and one region responsible for the proteolytic 
activity. Any alteration in the conformation of either of 
these proposed regions could result in the loss of the 
hemorrhagic response. Perhaps future research will one day 
clarify the relationship between the proteolytic activity 
of a toxin and it's presence or absence of hemorrhagic 
activity. 
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HTb is not vastly different from other hemorrhagic 
toxins thus far isolated from snake venoms, although it is 
the most basic toxin reported. Not all toxins isolated 
have had exact isoelectric points determined. It is 
possible that there are other hemorrhagic toxins with 
isoelectric points as basic as HTb, perhaps even more so. 
However, for those reported with pi values, HTb is the only 
one above 10 (based on the present study). Hemorrhagic 
toxins have been isolated from both crotalid and viperid 
species, with molecular weights ranging from 22,000 to 
115,000 daltons. As previously stated, all have 
proteolytic activity on at least one substrate provided 
glomerular basement membrane is included as a substrate. A 
unique feature of HTb as compared to most other hemorrhagic 
toxins, however, is it's ability to induce myonecrosis. 
Two other hemorrhagic toxins, mucrotoxin A (Sugihara et 
al., 1983) and viriditoxin (Fabiano and Tu, 1981), from the 
venoms T. flavovirids and ~ ~ viridis, respectively, have 
also been reported to cause myonecrosis. Gleason et al. 
(1983), however, have concluded for viriditoxin that 
myonecrosis due to this venom results not from a direct 
myotoxic activity of the toxin, but from ischemic 
conditions created by the hemorrhage. There is still some 
question as to the direct myotoxic effects of the remaining 
two hemorrhagic-myotoxins. 
The complexity of rattlesnake venoms makes the study 
of their biological actions very difficult. The use of 
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purified components will certainly be an advantage in 
describing the pathogenesis of the sequelae typical of 
these venoms. The pathogenesis of myonecrosis induced by 
myotoxins isolated from~ asper venom (Gutierrez et al., 
1984) and~~ viridis venom (Ownby et al., 1976) has been 
described. The ability of an antiserum to myotoxin ~ to 
neutralize the myotoxic effects of the toxin and the crude 
~ ~ viridis venom has been described by Ownby et al. 
(1983). The purified HTb described in this chapter has been 
used to produce an antibody. The toxin and the antibody 
have been used to measure the presence of HTb or similar 
toxins in other venoms and to study one aspect of the 
pathogenesis of the myonecrosis induced by the toxin. In 
addition, the ability of the antibody to neutralize the 
hemorrhage induced by the purified toxin has been measured. 
The results are described in the following chapters. 
CHAPTER IV 
AFFINITY PURIFICATION OF ANTIBODIES TO 
HTB: ABILITY TO NEUTRALIZE HEMORRHAGE 
Introduction 
The inability of polyvalent antivenoms to neutralize 
local and lethal effects of snake venom poisoning (Minton, 
1954; Ownby et al., 1983) has resulted in attempts to 
develop more effective antisera. Ownby et al. (1985; 1986) 
have shown more effective prevention of myonecrosis induced 
by Crotalus viridis viridis venom and myotoxin ~ with a 
mixture of an antiserum produced against myotoxin ~ and 
Wyeth's polyvalent (Crotalidae) antivenin, both in vitro 
and in vivo. Tan (1983) demonstrated an improvement in 
protection against lethality due to the Malayan cobra by 
conjugating the toxic low molecular weight components 
present in this venom to a neurotoxin isolated from the 
venom of Enhydrina schistosa. Another method utilized in 
hopes of producing better antisera is the affinity 
purification of antibodies, both to crude venoms and to 
purified toxins. Yang et al. (1977) showed an improvement 
in the neutralization of lethal effects induced by 
cobrotoxin using affinity-purified antibodies to this 
toxin. Lomonte et al. (1985) purified antibodies to a 
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myotoxin by this technique from the polyvalent antivenom 
used against the venom Bothrops asper that were more 
effective in neutralizing myotoxic effects caused by the 
crude venom. Lee and Chao (1978) demonstrated a 29.6-fold 
increase in neutralizing capacity of affinity-purified 
antibodies to Bungarus multicinctus as compared to the 
polyvalent antivenom produced against the crude venom. 
These results encourged the development of an affinity-
purified antibody to purified hemorrhagic toxin b (HTb) in 
hopes of eventually improving the ability of commercial 
antisera to neutralize toxins and better treat snake venom 
poisoning. The production and affinity-purification of 
antibodies to HTb and their ability to neutralize 
hemorrhage in vitro is presented. 
Materials and Methods 
Hemorrhagic Toxin b 
91 
HTb was isolated as previously described (Chapter 
III). Briefly, 2.0 grams of desalted crude Crotalus atrox 
venom was purified by a four-step chromatographic procedure 
utilizing anion exchange, gel filtration, cation exchange, 
and hydrophobic interaction chromatography. The purified 
toxin thus obtained contained only a single protein band 
after analysis by SDS-PAGE, and was considered homogenous. 
The toxin was desalted, diafiltered into 0.01 M Na-MOPS, pH 
7.2, and stored at -20°C until needed. 
92 
Anti-HTb serum 
One ml of Freund's complete adjuvant was mixed with 
one ml of a 0.1 mg/ml solution of purified HTb and injected 
i.m. between the shoulder blades of a New Zealand white 
female rabbit. Booster injections were of the same 
concentration of HTb, but were mixed with one ml of 
Freund's incomplete adjuvant. Booster injections were 
administered two weeks following the initial injection of 
toxin and subsequently at monthly intervals. Approximately 
two weeks following the second and third booster 
injections, the rabbit was bled from the marginal ear vein. 
Serum was collected and stored at -20°C until needed. 
Affinity Column Preparation 
Approximately 27 mg of HTb was conjugated to eight ml 
of an Affi-Gel 10 agarose gel bead support (Bio-Rad Corp.) 
in 0.1 M Na-MOPS, ph 7.0, overnight at 4°C. The gel was 
packed into a 1.5 X 12 em glass chromatography column and 
equilibrated in phosphate buffered saline, pH 7.4 (Sigma 
Chemical Co.). The four eluants to be used, PBS, 0.05 M 
acetic acid, and distilled water were applied to the column 
and fractions were collected and measured for protein to 
ensure that HTb would remain bound to the column. Protein 
concentration of the fractions was measured with the 
protein determination method of Bradford (1976). 
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Affinity Purification of Antibodies 
Prior to application to the column, the crude rabbit 
serum was centrifuged at 40,060 g, 4°C, in a Sorvall SM-24 
centrifuge (Dupont Corp.) for 30 min. One ml of the 
supernatant was applied to the affinity column and eluted 
with PBS at a flow rate of 5.0 ml/hr until elution of the 
unbound fraction was complete. The column was then 
successively eluted with distilled water, 0.05 M acetic 
acid, and then re-equilibrated in PBS. Fractions of 2.2 ml 
were collected and the absorbance at 280 nm was read using 
a Beckman DU-8 spectrophotometer (Beckman Corp., Irvine, 
CA). The peak eluting with the acetic acid was subjected 
to a buffer exchange, into 0.01 M Na-MOPS buffer, pH 7.2, 
in an Amicon ultrafiltration cell and pooled, concentrated, 
and stored frozen until use. 
Enzyme-Linked Immunosorbent 
Assay (ELISA) 
The composition of reagents used for the ELISA were as 
follows: (a) coating buffer - 0.015 M sodium bicarbonate, 
0.035 M sodium carbonate, 0.003 M sodium azide, 1% BSA; (b) 
washing buffer - 0.15 M Nacl, 0.05% Tween 20; (c) 
incubation buffer - 0.05% Tween 20, 0.003 M sodium azide, 
1% BSA, dissolved in PBS; (d) diethanolamine buffer -0.1 M 
diethanolamine-Cl, 0.0011 M magnesium chloride, pH 9.8; (e) 
phosphatase substrate - p-nitrophenyl phosphate disodium, 
40 mg/ml, dissolved in diethanolamine buffer. The 
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immunological activity of the fractions eluting from the 
column was monitored using the ELISA technique. 
Polystyrene microtiter plates (Flow Laboratories, McLean, 
VA) were coated with 0.2 ml of a 1.0 mg/ml solution of HTb, 
0 diluted in coating buffer, overnight at 4 c. The plates 
were washed 3 X 5 min with washing buffer followed by 
addition of 0.2 ml of each fraction from the affinity 
column for 2 hr at room temperature. The plates were 
washed 3 X 5 min with washing buffer and 0.2 ml of a 1/2000 
dilution of goat anti-rabbit IgG conjugated to akaline 
phosphatase diluted in incubation buffer was added and 
allowed to incubate for 2 hr at room temperature. The 
plates were washed 3 X 5 min with washing buffer. For 
color development, 0.2 ml of phosphatase substrate was 
added and allowed to incubate for 30 min at room 
temperature. The absorbance at 405 nm was measured using 
an EIA ELISA manual reader (Biotek Instruments, Inc.). 
Immunodiffusion 
The Ouchterlony double-diffusion technique (Clausen, 
1969) was used to detect precipitation reactions between 
HTb, crude venom and antibodies present in the crude serum, 
polyvalent antivenin, and the affinity-purified antibody 
solutions. Serial two-fold dilutions, from undiluted to 
1/32, of a 1.0 mg/ml solution of HTb and the crude venom 
were tested against the same dilutions of concentrated 
polyvalent antivenin and rabbit antiserum to HTb. The 
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affinity antibodies were diluted as above, but the 
undiluted material was 0.76 mg/ml. The gels were of 1% 
agarose dissolved in PBS, pH 7.4. The gels were 10 X 15 em 
and the distance between wells was 1.0 em. Each well 
received 0.02 ml of the test solutions, and the gels were 
allowed to incubate in a humid chamber at room temperature 
for 24 hr. The gels were washed for 24 hr in PBS and 
stained with Crowle double stain (Crowle and Cline, 1977), 
dried, and photographed. 
Western Blot Technique 
The specificity of the affinity purified antibody was 
measured using the western blot immunoblotting technique 
according to the method of Towbin et al. (1979). HTb was 
electrophoresed on a 10% SDS polyacrylamide gel, with 0.005 
mg protein/well, and electrophoretically transferred to a 
nitrocellulose membrane in a Hoeffer Scientific Instruments 
(San Francisco, CA) transfer unit cooled to 15°c. The 
nitrocellulose membrane was washed two times at 5 min in 
0.5 M NaCl containing 20 mM Tris-Cl buffer (TBS) and then 
coated for 2 hr in three concentrations of primary 
antibody. These concentrations were 0.01 mg/ml, 80 ng/ml, 
and 0.64 ng/ml. The membrane was washed twice in TBS, 
twice in TBS containing 0.05% Tween 20, all at 5 min, and 
twice in distilled water for a total of 2 min. Protein A-
colloidal gold was applied to the membrane for 4 hr, 
followed by two washings in TBS for five minutes each, 
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thorough rinsing in distilled water, and equilibration in 
0.2 M citrate buffer for 5 min. The bands made visible 
with the protein A-colloidal gold were enhanced with 0.11% 
silver lactate dissolved in 0.85% hydroquinone for 5 min, 
giving rise to distinct dark bands. Following enhancement, 
the membrane was fixed in fixing solution for 5 min. The 
staining procedure described above was performed using the 
Protein A Gold Immun-blot assay kit obtained from Bio Rad 
Laboratories (Richmond, CA), catalog number 170-6510. 
Minimum Hemorrhagic Dose Determination 
The minimum hemorrhagic dose (MHD) of HTb was 
determined with the method of Kondo (1960). Briefly, the 
method involved the intradermal injection of 0.05 ml of the 
test solution into the shaved backs of mice. Six hr post-
injection, the mice were killed with ether and the skin 
removed, placed between two glass plates, and examined on 
the inside surface. The hemorrhagic spot was measured at 
the widest point. A second measurement at right angles to 
the first was also made. The average of these two 
measurements was recorded as the hemorrhagic spot size. 
Three doses of HTb, 0.1 mg/kg, 0.3 mg/kg, and 0.5 mg/kg, 
were tested in three groups of five mice each. A dose 
response curve was then used to determine the MHD, that 
dose producing a spot size of 10.0 mm. 
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Neutralization of Hemorrhage 
The ability of the affinity-purified antibodies to HTb 
and Wyeth's polyvalent (Crotalidae) antivenin to neutralize 
hemorrhage in vitro was tested with Kondo's method. The 
toxin was concentrated to ten times one MHD, and 0.1 ml of 
this solution was added to 0.9 ml of the antisera, giving a 
1/10 dilution of the toxin, or one MHD. The test solution 
0 
was allowed to react overnight at 4 c. The solution was 
centrifuged for 2 min in an Brinkman 3200 microfuge to 
remove any precipitate. The following solutions were 
tested for their neutralization ability: 1.79, 8.26, and 
16.20 mg/ml solutions of affinity-purified antibodies to 
HTb, reconstituted concentrated polyvalent antivenin, crude 
rabbit serum containing antibodies to HTb, preimmune rabbit 
serum, normal horse serum, and PBS. Controls included 
normal rabbit and horse serum and PBS. 
Statistical Analysis 
An analysis of variance was performed to determine 
significance of variation within treatments and the least 
significant difference test was used to determine 
significance of differences in treatment means. 
Significance was recorded at p < 0.01. 
Results 
Affinity Column and Antibody 
Purification 
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A high coupling efficiency for covalent attachment of 
purified HTb to the affinity matrix as evidenced by the 
absence of protein eluting from the column during the 
washing procedures was expected since the protein binding 
capacity of the column (35 mg/ml of gel) exceeded the 
amount of toxin added. Also, none of the elution 
conditions, including PBS, distilled water, or 0.05 M 
acetic acid, resulted in loss of the toxin from the column. 
Figure 8 is a typical elution profile obtained with 
the Affi-Gel 10 affinity column. Also presented on this 
graph is the absorbance at 405 nm, the results of the ELISA 
of the column fractions. With the exception of the unbound 
fraction, the largest protein peak, eluted with the acetic 
acid in tubes 35 through 58. This fraction also contained 
the highest antibody concentration as measured with the 
ELISA and was therefore collected and used in the 
subsequent immunodiffusion and neutralization studies. 
Minimum Hemorrhagic Dose 
The MHD was determined to be 0.3 mg/kg based on three 
doses tested, five mice per dose. The mean values for each 
dose were 0.1 mg/kg = 2.80 mm; 0.3 mg/kg = 10.4 mm; 0.5 
mg/kg = 19.4 mm. In most cases, the hemorrhagic spot was 
Figure 8. Elution profile of the affinity-purification of 
antibodies to HTb from of 1.0 ml crude rabbit 
serum immunized against 0.1 mg HTb. ELISA 
results showing antibody activity. The left-
hand scale represents protein determination by 
absorbance of each fraction at 280 nm; the 
right-hand scale is a measure of antibody 
content as determined with the ELISA at 405 
nm. The affinity column was equilibrated in 
PBS and the sample was applied at a flow rate 
of 5.0 ml/hr. DW = distilled water; Acetic = 
0.05 M acetic acid, pH 3.0; PBS = phosphate 
buffered saline, pH 7.4. Fraction size was 
2.2 ml/tube. Column size: 1.0 X 12 em. 
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clearly delineated and relatively round. 
Immunodiffusion 
Figure 9 shows the immunodiffusion results of each 
antisera against the crude c. atrox venom. Wyeth's 
polyvalent antivenin produced two precipitin bands against 
the crude venom. One band was at an approximate point of 
equivalence at a 1/8 dilution of the crude venom, while the 
other precipitin band was at an approximate point of 
equivalence at a 1/2 dilution of the crude venom (Figure 9 
A and B). A single band was visible when the crude rabbit 
antiserum was tested against the venom, with an approximate 
equivalence point at a 1/4 dilution of the crude venom 
(Figure 9 c and D). A single band was also visible when 
the affinity antibody was tested against the crude venom, 
with the equivalence point occurring when both test 
solutions were undiluted (Figure 9 E and F). 
Figure 10 shows the results of the antisera tested 
against the purified HTb. A single band was visible for 
all three antisera when tested against the purified HTb. 
The undiluted Wyeth's antivenin and the rabbit antiserum 
had equivalence points only at the most dilute 
concentration of HTb, a 1/32 dilution (Figure 10, A and B, 
C and D). The affinity-purified antibodies produced a band 
with a zone of equivalence when the test solutions were 
both undiluted (Figure 10 E and F). 
Figure 9. Results of the immunodiffusion assay testing 
crude c. atrox venom versus polyvalent 
antivenin, crude rabbit antiserum, and the 
affinity-purified antibodies to HTb. 
A= Wyeth's polyvalent antivenin; 
C = crude rabbit antiserum; 
E = affinity-purified antibodies; 
B, D, F = c. atrox venom; 
Dilutions of antisera and venom: (1) 1/32, 
(2) 1/16, (3) 1/8, (4) 1/4, (5) 1/2, 
(6-11) undiluted. 
B 
1110 9 8 7 6 54 
c 
1 2 3 ~-
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E 
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Figure 10. Results of the immunodiffusion assay testing 
purified HTb against polyvalent antivenin, 
crude rabbit antiserum, and affinity-purified 
antibodies against HTb. 
A= Wyeth's polyvalent antivenin; 
c = crude rabbit antiserum; 
E = affinity-purified antibodies; 
B, D, F = Purified HTb; 
Dilutions of antisera and venom: (1) 1/32, 
(2) 1/16, (3) 1/8, (4) 1/4, (5) 1/2, 
(6-11) undiluted. 
A 1 2 .- • ._ 
.~ .... ~~.-..:3 
B 
11 10 9 8 7 6 5 4 3 2 1 
c 1 2 3 A~~~~~~---· 
D 
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F 11 10 9 8 7 6 5 4 3 2 1 
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Western Blot 
Figure 11 shows the results of the western blot. In 
lane one were the molecular weight standards. Lane 2 
contained the HTb following cation exchange chromatography, 
which showed a very faint second band with an approximate 
molecular weight of 14,000 daltons. Lanes 3, 4, and 5 
contained purified HTb with antibody concentrations of 0.64 
ng/ml, 80 ng/ml, and 0.01 mg/ml, respectively. At all 
antibody concentrations, only one band was demonstrable, 
indicating the specificity of the antibody. 
Neutralization of Hemorrhage 
Partial neutralization of hemorrhage was acheived with 
the affinity-purified antibody solution at a concentration 
of 8.3 mg/ml, while 100% neutralization was observed when 
the concentration was 16.2 mg/ml. All other test solutions 
were ineffective in reducing or preventing hemorrhage 
induced by HTb. The results of the tests are presented in 
Figure 12. The control solutions, PBS, normal rabbit 
serum, and normal horse serum, produced no hemorrhage. 
Only the last two antisera solutions, consisting of the 
affinity antibodies, were significant in neutralizing 
capacity. Complete neutralization was at a molar ratio of 
approximately 15.6 moles antibody to one mole of toxin, 
based on molecular weights of 160,000 daltons and 24,000 
daltons, respectively. The polyvalent antivenin caused a 
slight, though insignificant, increase in hemorrhage. 
Figure 11. Western blot of HTb using affinity purified 
antibodies specific for HTb. The stain was 
silver enhanced according to BIO-RAD Protein 
A Gold Immun-Blot assay kit. Lane 1: 
molecular weight standards (myosin, 205,000 
daltons; beta-galactosidase, 116,000; 
phosphorylase b, 97,000; bovine serum 
albumin, 66,000; egg albumin, 45,000; 
glyceraldehyde, 36,000; carbonic anhydrase, 
29,000; trypsiongen, 24,000; trypsin 
inhibitor, 20,100; and alpha-lactalbumin, 
14,200); lane 2: HTb following cation 
exchange chromatography (note second faint 
band at approximately 14,000 daltons); lanes 
3, 4, and 5: purified HTb (following 
hydrophobic interaction chromatography) with 
antibody concentrations of 0.64 ng/ml, 80 
ng/ml, and 0.01 mg/ml respectively. 
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Figure 12. Results of the in vitro neutralization of 
hemorrhage induced by HTb, testing 
neutralization capacities of Wyeth's 
polyvalent antivenin, crude rabbit antiserum 
to HTb, and three concentrations of the 
affinity-purified antibodies to HTb- 1.79 
mg/ml, 8.26 mg/ml, and 16.2 mg/ml. Bars are 
plotted as the mean hemorrhagic spot size + 
standard deviations. PBS = phosphate 
buffered saline, pH 7.4; Wyeth's =polyvalent 
(Crotalidae) antivenin; RS = crude rabbit 
serum immunized against HTb; Ab = affinity 
antibody at the specified concentration. * 
Significant at the p < 0.01 level compared to 
the PBS + HTb group. 
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Discussion 
Antibodies specific for HTb have been isolated using 
affinity chromatography from serum obtained from rabbits 
immunized with HTb • These antibodies form one precipitin 
band when tested against crude ~ atrox venom and purified 
HTb using immunodiffusion in agarose gels. The MHD dose 
for HTb reported here, 0.3 mg/kg, agrees with that 
previously reported by Bjarnason and Tu (1978), also 0.3 
mg/kg. 
Wyeth's polyvalent antivenin has been shown to be 
quite effective in neutralizing hemorrhagic effects of 
crude venoms. Ownby et al. (1984) reported complete 
neutralization of a 6.0 mg/kg dose of C. atrox venom and a 
12.0 mg/kg dose of ~ ~ viridis. Smith and Ownby (1985) 
reported the ability of antivenin to neutralize a 12.0 
mg/kg dose of ~ horridus horridus venom. The results 
presented here demonstrate that polyvalent antivenin has 
little capacity to neutralize hemorrhage induced by HTb. 
This is most likely due to the low titer of antibodies 
present in the antiserum directed against HTb, despite the 
fact that the concentration of HTb in c. atrox venom is 
greater than the other hemorrhagic toxins found in this 
venom (Bjarnason and Tu, 1978) and that this venom is used 
in the immunization protocol for production of the 
antiserum. Minton (1954) reported the inability of 
polyvalent antivenin to neutralize lethal effects of c. 
atrox or ~ adamanteus venom, both of which are used in the 
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production of the antivenin. In the present study, the 
polyvalent antivenin actually resulted in an increased, 
though insignificant, hemorrhagic response. Ownby et al. 
(1983) demonstrated an exacerbation of vacuolation of 
muscle cells induced by ~ ~ viridis venom when the venom 
was mixed with polyvalent antivenin. Similar results were 
observed with~~ horridus venom (Smith and Ownby, 1985). 
Ownby and Colberg (1986) reported the ability of polyvalent 
antivenin to neutralize myonecrosis induced by a 15.0 mg/kg 
dose of ~ atrox venom, which is significantly better than 
that reported for either ~ ~ viridis venom or ~ ~ 
horridus venom. 
In contrast, the affinity-purified antibodies did 
neutralize the hemorrhagic activity of the toxin, but only 
at very high concentrations. Complete neutralization was 
accomplished when the antibody/toxin ratio was 104.6 mg 
antibody/1.0 mg toxin. Lomonte et al. (1985) used 
affinity-purified antibodies specific for a myotoxin 
isolated from the venom of ~ asper. These antibodies were 
effective in neutralizing myonecrosis induced by the crude 
venom, but only at a ratio of 29 mg antibody/1.0 mg venom. 
This antiserum was not effective in neutralizing lethal 
effects of the crude venom. The poor ability of the 
affinity-purified anti-HTb immunoglobulins to reduce 
hemorrhage may be due to a low affinity for the toxin. 
However, elution of the antibodies from the affinity column 
required 0.05 M acetic acid at a pH of 3.0, suggesting that 
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the the affinity was relatively high. In addition, this 
was a precipitating antibody, though the ability of 
antibodies to precipitate with the antigen may be 
insignificant. Chang and Yang (1977) used an affinity-
purified antibody fraction from serum immunized against 
cobrotoxin which showed a 23-fold increase in neutralizing 
capacity for lethal effects that proved not to be a 
precipitating antibody. Bober (1987) produced an affinity-
purified antibody to myotoxin ~ that was nonprecipitating 
and incapable of neutralizing myonecrosis induced by the 
toxin. 
Despite the need for high concentrations of the 
affinity antibody to neutralize hemorrhage, the fact that 
neutralization was possible is promising since polyvalent 
antivenin, the commercial antivenom used for treatment of 
rattlesnake venom poisoning in the United States, proved 
completely ineffective in reducing hemorrhagic activity of 
the toxin. Tan (1983) reported the production of a very 
effective antiserum against lethal effects of the Malayan 
cobra by chemically cross-linking the major toxins from 
this venom with a neurotoxin from a sea snake. Perhaps the 
immunogenicity of HTb, or other purified toxins important 
in venom poisoning sequelae, could be improved by such 
measures, including the conjugation of the toxins to larger 
or more strongly immunogenic carriers, thereby increasing 
the liklihood of the presence of antibodies in the 
antiserum used to treat snake bites. 
CHAPTER V 
DETECTION OF HEMORRHAGIC TOXIN B FROM 
CROTALUS ATROX VENOM IN 
OTHER SNAKE VENOMS 
Introduction 
Hemorrhagic toxin b (HTb) is a metalloprotease present 
in the venom of the western diamondback (Crotalus atrox) 
rattlesnake. It has an approximate molecular weight of 
23,000 daltons, is highly basic with an isoelectric point 
above ten, and requires zinc for proteolytic and 
hemorrhagic activity (Bjarnason and Tu, 1978). It 
comprises at least 3.7% of the crude protein in the venom, 
and is one of seven hemorrhagic toxins found in c. atrox 
venom. HTb is also capable of inducing myonecrosis (Ownby 
et al., 1978). 
Most rattlesnake venoms induce hemorrhage, a serious 
sequelae to venom poisoning. Of eleven rattlesnake venoms 
tested, Friederich and Tu (1971) found that only the Mojave 
rattlesnake (~ scutulatus) was nonhemorrhagic. Several 
hemorrhagic toxins have been isolated from snake venoms, 
including venoms of the following genera: Crotalus, 
Agkistrodon, Trimersurus, Bothrops, and Vipera. The 
predominance of hemorrhagic toxins in venoms indicates the 
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importance of this reaction medically. If a particular 
hemorrhagic toxin is widely distributed in a variety of 
snake venoms, then an antivenom to be used in treatment 
must contain antibodies to this toxin. The currently used 
antivenom in the United States, Wyeth's polyvalent 
(Crotalidae) antivenin, has been shown to be moderately 
effective in neutralizing hemorrhagic effects of 
rattlesnake venoms in vitro (OWnby et al., 1984a; Smith and 
OWnby, 1985). However, this antivenom was ineffective in 
preventing hemorrhage induced by HTb (Chapter IV). This 
result was surprising because this toxin comprises 
approximately 3.5% of the crude venom protein, the c. atrox 
venom from which it was isolated is used in the 
immunization protocol for production of the polyvalent 
antivenin, and that the polyvalent antivenin does contain 
antibodies to the toxin (Chapter IV) as measured with 
immunodiffusion. Consequently, little reduction in 
hemorrhage due to HTb, or similar toxins, would be expected 
clinically when polyvalent antivenin is used. It is 
therefore important to determine the presence of this 
potent hemorrhagin in other snake venoms. 
Bober (1987), using the ELISA and an affinity purified 
antibody to myotoxin ~' a myotoxin isolated from the venom 
of~ viridis viridis (OWnby et al., 1976), screened 
eighty-two venoms from six genera for the presence of 
myotoxin ~· Previous reports have demonstrated the 
ineffectiveness of polyvalent antivenin to prevent myotoxic 
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effects of C. v. viridis venom (OWnby et al., 1983a), and 
the low titer of antibodies to this toxin in the polyvalent 
antivenin (Ownby et al., 1983b). Bober (1987) found 
detectable levels of myotoxin ~ in thirty-five of the 
venoms tested, all from members of the genus Crotalus. 
The present study describes the use of ELISA in 
screening venom samples representing fifty-three species 
and subspecies of snakes for the presence of HTb, or cross-
reacting proteins, using the affinity-purified antibody 
previously described. Also recorded are the geographical 
locations of the snakes used in the study, where available. 
Materials and Methods 
Hemorrhagic Toxin b 
HTb was isolated as previously described (Chapter 
III). Briefly, 2.0 grams of desalted crude Crotalus atrox 
venom was purified by a four-step chromatographic procedure 
utilizing anion exchange, gel filtration, cation exchange, 
and hydrophobic interaction chromatography. The purified 
toxin thus obtained contained only a single protein band 
after analysis by SDS-PAGE, and was considered homogenous. 
The toxin was desalted, diafiltered into 0.01 M Na-MOPS, pH 
0 7.2, and stored at -20 C until needed. 
Affinity Purification of 
Antibodies to HTb 
Affinity purification of antibodies to HTb was 
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conducted as described previously in Chapter IV. Briefly, 
serum from rabbits immunized with HTb was applied to an 
affinity column consisting of 8.0 ml of Affi-Gel 10 
affinity matrix conjugated with 27.0 mg of purified HTb. 
After elution of unbound serum components, HTB-specific 
antibodies were eluted with 0.05 M acetic acid, pH 3.0. 
Antigen Detection ELISA 
The composition of reagents used for the ELISA were as 
follows: (a) coating buffer - 0.015 M sodium bicarbonate, 
0.035 M sodium carbonate, 0.003 M sodium azide, 1% BSA; (b) 
washing buffer - 0.15 M Nacl, 0.05% Tween 20; (c) 
incubation buffer - 0.05% Tween 20, 0.003 M sodium azide, 
1% BSA, dissolved in PBS; (d) diethanolamine buffer - 0.1 M 
diethanolamine-Cl, 0.0011 M magnesium chloride, pH 9.8; (e) 
phosphatase substrate- p-nitrophenyl phosphate disodium, 40 
mg/ml, dissolved in diethanolamine buffer. Microtiter 
plates (Flow Laboratories) were coated overnight at 4°c 
with 0.2 ml of antibodies to HTb at a concentration of 
0.001 mg/ml, diluted in coating buffer. The plates were 
washed 3 X 5 min with washing buffer, followed by the 
addition of 0.2 ml of known amounts of HTb, ranging in 
concentrations from 0.01 mg/ml to 1000 ng/ml, for 2 hr at 
37°c. Blank wells, containing only incubation buffer, were 
also run with each plate. The plates were washed 3 X 5 min 
with washing buffer, followed by a 2 hr incubation with 0.2 
ml affinity-purified antibodies at a concentration of 0.001 
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mg/ml at 37 c. After washing 3 X 5 min with washing 
buffer, 0.2 ml of secondary antibody, goat anti-rabbit IgG 
antibody (Sigma Chemical Co.), conjugated with alkaline 
phosphatase, diluted 1/2000 in incubation buffer, was added 
0 for 2 hr at 37 c. The plates were again rinsed for 3 X 5 
min with washing buffer and 0.2 ml of the enzyme substrate, 
p-nitrophenyl phosphate disodium (Sigma Chemical Co.), was 
added and allowed to incubate at room temperature for 30 
min. The enzyme/substrate reaction was stopped with the 
addition of 0.05 ml 3 N NaOH. Absorbance at 405 nm was 
determined with an EIA Manual ELISA spectrophotometric 
reader. 
Assay of Venoms for HTb 
Fifty-three venoms samples, representing six genera, 
were tested for the presence of HTb, or cross-reacting 
proteins, using the antigen-detection ELISA method. The 
venoms were generously supplied by Jim Glenn, Salt Lake 
City, Utah. They were obtained from snakes collected over 
wide geographic areas and consisted of both males and 
females. One venom sample was from a snake captured in 
Costa Rica, while the others were collected from various 
regions in Mexico and the following ten states: Florida, 
Georgia, North Carolina, New Mexico, Utah, Arizona, 
Montana, Colorado, Wyoming, and South Dakota. Each venom 
was tested initially at a concentration of 1.0 mg/ml. 
Those venoms producing values greater than 1.0 absorbance 
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units were diluted 1/100 (0.01 mg/ml) and tested. Again, 
any reading above 1.0 absorbance units were diluted 1/10 
(1000 ng/ml) and tested. One venom was diluted to 100 
ng/ml. All venoms were originally tested once on each of 
three plates, recorded as values at n=3. Many of these 
venoms were tested again, repeated five times on one plate, 
recorded as values at n=5. Also, serial two-fold dilutions 
of five venoms were measured to test the validity of the 
technique, insuring that a 50% dilution resulted in an 
approximate reduction by 50% of the absorbance value. A 
standard curve of HTb was run with each plate as a positive 
control. 
Statistical Analyses 
A student's t-test was used to determine significance 
between treatment means at the p < 0.05 level. Mean 
absorbance values for each venom were tested against mean 
absorbance values for the incubation buffer blanks. At 
n=3, the means of two blank wells/plate were averaged for 
the three plates. At n=5, each venom mean was tested 
against the mean of five blank wells from the single plate. 
Results 
Antigen Detection ELISA 
Figure 13 is a diagram illustrating the steps of the 
ELISA antigen detection plate. Incubation control blanks, 
a measure of nonspecific binding, were very low, with 
Figure 13. A flow chart illustrating the steps involved in 
the hemorrhagic toxin b detection plate. 
ELISA FOR HENORRHAGIC TODl\ b DETECTIO\' 
1. A.11 ti-HTb Adsorbed to Plate 
2. Solution Containing HTb () Added 
I-' ASH 
+ 
3. Solution Containing J\nti-BTb '\:::J Added w 
.... 
4. Alkaline Phosphatase Labelled 
Antibody to Rabbit IgG ~Added 
\\'ASH 
E-i._0JE 
5. EnzYwe Substrate 0 Added 
INCUBATE 
+ 
6. Read Absorbance of Reaction 
Product D at 405 nm 
D D 
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values ranging between 0.084 and 0.191 absorbance units. 
Table VI illustrates the values obtained with a standard 
curve, measuring dilutions of HTb. The values are recorded 
as the mean (n = 4) of absorbance units at 405 nm + the 
standard error. The blanks were subtracted from the 
absorbance readings. 
Assay of Venoms for HTb 
Results of the ELISA for the detection of HTb in the 
venom samples are presented in Table VII. Four of the five 
genera evaluated contained venoms testing positive for HTb. 
Only the genus Naja, with the single venom from N. n. 
kaouthia (Thailand cobra), tested negative. Of the 
remaining fifty-two venom samples, forty (75.5%) tested 
positive for HTb. Twenty-three of the venoms had values 
above 1.0 and were tested at 0.001 mg/ml. All tested 
positive at this dilution. Of these, ten venoms had values 
above 1.0 and were tested at a concentration of 1000 ng/ml. 
Again, all tested positive. One venom, obtained from C. 
mitchelli pyrrhus, tested positive at a concentration of 
100 ng/ml. Table VIII represents the data obtained in 
testing the dilutions of five venoms, ~ lepidus klauberi, 
~ m. pyrrhus, ~ exsul, c. ~ abyssus, and A. contortrix 
mokeson, demonstrating high correlation between 
concentrations of venom and the absorbance at 405 nm. 
There was marked variation in the presence of HTb in 
venoms from the same genus. For example, two species from 
TABLE VI 
DETECTION OF HTb USING ELISA 
HTb Absorbance 
(microgm/ml) (405 nm) 
10.0 0.980 + 0.17 
-
8.0 0.754 + 0.06 
5.0 0.457 + 0.05 
-
3.0 0.181 + 0.03 
-
1.0 0.077 + 0.02 
-
I.B. 0.138 + 0.02 
-
(r=0.99) 
HTb was assayed using one well/plate over four plates. The 
values are expressed as mean + standard error. 
(n = 4) 
I.B. = incubation buffer blank with 1% bovine serum albumin. 
The background values have been subtracted from each 
absorbance reading. 
r = sample correlation coefficient 
Venom 
A. bilineatus bilineatus 
Miami Serpentarium 
A. contortrix contortrix 
Biotoxins, Inc. 
A. contortrix mokeson 
Miami Serpentarium 
TABLE VII 
DETECTION OF HEMORRHAGIC TOXIN B IN SNAKE 
VENOMS USING ELISA 
1. 0 mg/ml 0.01 mg/ml 
0 (3) 
*0.274 ± 0.020 (3) 
*1.590 ± 0.046 (3) *0.527 + 0.052 (3) 
~ pictigaster pictigaster *1.062 ± 0.066 (5) *0.157 ± 0.012 (5) 
Miami Serpentarium 
fh. asper *0.044 ± 0.005 (5) 
Costa Rica 
c. adamanteus *0.310 ± 0.069 (3) 
Florida 
c. atrox *0.300 + 0.029 ( 3) 
Texas 
c. basiliscus basiliscus * > 2.0 ( 3) *0.469 ± 0.046 (3) 
unknown origin 
0.001 mg/ml 
TABLE VII (Continued 
Venom 1. 0 mg/ml 0.01 mg/ml 0.001 mg/ml 
c. catalinensis 0.012 ± 0.006 (3) 
Baja, Mexico 
c. cerastes cerastes *0.195 + 0.023 ( 3 ) 
Utah 
c. cerastes cerastes *1.336 ± 0.191 (3) *0.146 ± 0.010 (5) 
Miami serpentarium 
c. durissus culminatus *0.224 ± 0.029 (5) 
Houston Zoo 
c. durissus durissus * > 2.0 (3) *1.530 ± 0.139 (3) *0.111 + 0.007 ( 5 ) 
unknown origin 
c. durissus totonacus *0.096 ± 0.007 (5) 
unknown origin 
~ enyo enyo 0 (3) 
Baja, Mexico 
~ enyo enyo 0.016 + 0.008 (3) 
Baja, Mexico 
c. exsul * > 2.0 (3) *0.512 + 0.075 ( 3 ) 
unknown origin 
c. exsul *0.224 ± 0.035 (3) 
unknown origin 
TABLE VII (Continued) 
Venom 1. 0 mg/ml 0.01 mg/ml 0.001 mg/ml 
c. horridus atricaudatus 0 ( 3 ) 
Valdosta, Georgia 
c. horridus atricaudatus 0.003 + 0.002 ( 5) 
North Florida 
c. horridus atricaudatus 0 (5) 
unknown origin 
c. horridus horridus *0.053 + 0.003 ( 5 ) 
North Carolina 
~ lepidus klauberi * > 2.0 (3) *0.977 + 0.064 ( 3 ) *0.198 + 0.009 ( 5 ) 
Zacatacus, Mexico 
~ lepidus klauberi * > 2.0 (3) *1.195 ± 0.191 (3) *0.136 + 0.003 ( 5) 
Zacatacus, Mexico 
~ lepidus klauberi *0.031 + 0.003 ( 5 ) 
Durango, Mexico 
~ lepidus klauberi *0.061 ± 0.005 (5) 
New Mexico 
C. mitchelli mitchelli 0.019 ± 0.005 (5) 
Baja, Mexico 
~ mitchelli pyrrhus * > 2.0 (3) *1.655 ± 0.248(3) *0.171 ± 0.004 (5) 
Bahia de los Angeles, Mexico 
~(' TABLE VII (Continued) 
Venom 1.0 mg/ml 0.001 mg/ml 0.0001 mg/ml 
~ mitchelli pyrrhus * > 2.0 (3) *1.095 ± 0.133 (3) *0.051 + 0.002 (5) 
Baja, Mexico 
~ mitchelli pyrrhus * > 2.0 (3) *0.449 ± 0.052 (3) 
Bahia de los Angeles, Mexico 
~ mitchelli pyrrhus * > 2.0 (3) * > 2.0 (3) * > 2.0 (3) 
Virgin River, Arizona 
~ mitchelli pyrrhus * > 2.0 (3) *1.357 ± 0.196 (3) *0.098 ± 0.003 (5) 
Utah 
~ mitchelli pyrrhus * > 2.0 (3) *0.593 ± 0.017 (3) 
Utah 
~ mitchelli pyrrhus * > 2.0 (3) *0.383 ± 0.016 (5) 
Utah 
~ mitchelli stephensi * > 2.0 (3) *0.326 ± 0.012 (3) 
unknown origin 
c. molassus molassus * > 2.0 (3) * > 2.0 (3) *0.336 + 0.012 (3) 
Miami Serpentarium 
~ molassus nigrescens * > 2.0 (3) *0.655 ± 0.144 (3) 
Durango, Mexico 
c. ruber ruber * > 2.0 (3) *0.335 ± 0.012 (3) 
Miami Serpentarium 
TABLE VII (Continued) 
Venom 1. 0 mg/ml 0.001 mg/ml 0.0001 mg/ml 
c. scutulatus scutulatus 0 ( 3) 
Miami Serpentarium 
~ vergrandis *0.516 ± 0.098 (3) 
Venezuela 
~ viridis abyssus * > 2.0 (3) *0.308 ± 0.007 (5) 
unknown origin 
c. viridis cereberus * > 2.0 (3) *0.399 + 0.028 (5) 
unknown origin 
c. viridis concolor 0.004 ± 0.006 (3) 
Sage Creek Den, Wyoming 
c. viridis helleri * > 2.0 (3) *1.251 ± 0.046 (3) *0.116 ± 0.006 (5) 
unknown origin 
c. viridis lutosus * > 2.0 (3) *1.191 ± 0.191 (3) *0.049 ± 0.008 (5) 
Magna, Utah 
~ viridis oreganus *0.040 ± 0.006 (5) 
Miami Serpentarium 
c. viridis viridis 0.012 ± 0.002 (5) 
Slater, Colorado 
c. viridis viridis *0.048 ± 0.005 (5) 
colorado 
TABLE VII (Continued) 
Venom 1.0 mg/ml 0.01 mg/ml 
c. viridis viridis *0.028 ± 0.004 (5) 
Colorado 
c. viridis viridis 0.017 ± 0.005 (5) 
Eddy County, New Mexico 
c. viridis viridis *0.156 ± 0.020 (3) 
Martin, South Dakota 
Naja naja kaouthia 0 (3) 
Miami Serpentarium 
Trimeresurus flavoviridis *0.471 ± 0.036 (5) 
Miami Serpentarium 
* significant at p < 0.05 
A.= Agkistrodon; C.= Crotalus; B.= Bothrops 
Results presented as absorbance value with blank value subtracted; 
number in parentheses indicates number of wells tested 
0.001 mg/ml 
Antigen c. klauberi 
(microgm/ml) -
40 
20 
10 
5 
2 
1 
0.625 
I.B. 
1.49 + .13 
0.83 + .13 
0.38 + .08 
0.11 + .04 
0.09 + .02 
0.10 + .003 
(r=0.99) 
TABLE VIII 
TEST OF VENOM DILUTIONS WITH ELISA 
f..!. pyrrhus 
1.11 ± .28 
0.70 + .20 
0.33 + .08 
0.22 + .04 
0.12 + .04 
0.10 + .003 
(r=0.99) 
f..!_ exsul 
ABSORBANCE 405 nm 
0.60 + .03 
0.39 + .04 
0.30 + .03 
0.17 + .14 
0.11 + .03 
0.01 + .003 
(r=0.97) 
c. abyssus 
0.56 + .04 
0.29 + .04 
0.21 + .03 
0.10 + .03 
0.01 + .003 
(r=0.99) 
A. mokeson 
0.42 + .04 
0.35 + .02 
0.23 + .04 
0.11 + .01 
0.01 + .003 
(r=0.92) 
Antigen = Venom sample. The venom samples were assayed as single wells from three plates. 
Expressed as the mean absorbance (405 nm) + standard error. 
I.B. = incubation buffer blank with 1% bovine serum albumin. The background values have 
been subtracted from each absorbance reading; r = sample correlation coefficient. 
(-) not assayed at this concentration; C.= Crotalus; A.= Agkistrodon. 
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the genus Agkistrodon had very high amounts of the toxin in 
their venoms, while two other species had very low amounts. 
This same type of variation was also observed within the 
same species. In two venom samples from ~ cerastes 
cerastes, one had very large amounts while the other had 
quite small amounts of HTb. Similar variations were 
observed within the following species: ~ exsul, C. 1. 
klauberi, and c. viridis subspecies. Other venom samples, 
such as those from ~ ~ pyrrhus, consistently had very 
high amounts of the toxin, while others, such as c. 
horridus atricaudatus, consistently had very low amounts of 
HTb. c. atrox venom, despite being the homologous venom 
from which the toxin was isolated, showed with the ELISA to 
have relatively small amounts of the toxin. 
The fifty-three venom samples tested showed a tendency 
towards geographic variation, with those from northern 
regions having less amounts of the toxin and those from 
more southern regions having higher amounts. This 
variation was only a tendency, however, since there were 
exceptions. 
Discussion 
The evaluation of venoms for common antigens, 
especially medically important components such as 
hemorrhagins, could be very useful for the development of 
snake bite treatments. For an antiserum to be effective 
against a given venom poisoning reaction, it must have 
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antibodies to those toxins responible for the reaction, 
especially if these toxins are ubiquitous among snake 
venoms. The enzyme-linked immunosorbent assay is an 
effective tool for the determination of common antigenic 
components in snake venoms. An affinity- purified antibody 
to HTb was produced and used to test fifty-three venom 
samples representing five genera for the presence or 
absence of this toxin. 
The large number of cross-reacting venoms indicates 
the potential importance of HTb in snake bites, expecially 
in those venoms containing relatively high amounts. 
Although polyvalent antivenin has been shown to be 
effective against hemorrhage induced by rattlesnakes (Ownby 
et al., 1984b; Smith and Ownby, 1985), neutralization 
studies reported in this paper demonstrate the 
ineffectiveness of polyvalent antivenin in reducing or 
preventing hemorrhage caused by HTb. This antiserum was 
unable to neutralize even a single minimum hemorrhagic 
dose. Since HTb is found in such a wide variety of snake 
species, an antiserum developed for the treatment of snake 
venom poisoning should be effective against HTb. 
The homologous crude venom, ~ atrox, showed 
relatively small amounts of HTb using the ELISA, despite 
the fact that the toxin represents 3.46% of the venom 
protein. These results could be due to an inhibition in 
the antigen-antibody reaction due to the high concentration 
of antibodies to HTb. Similar results were observed by 
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Ownby et al. (1983b) when the ELISA was used to measure 
antibody titers in antimyotoxin ~ serum, antiserum to ~ v. 
viridis venom, and Wyeth's polyvalent antivenin. It would 
also seem unlikely that such a large number of venoms would 
contain a toxin identical to HTb, and in some cases, in 
such large amounts. A more plausible explanation would be 
the presence of proteins with common antigenic sites 
capable of cross-reacting with the anti-HTb antibodies, 
proteins which may or may not have hemorrhagic activity. 
The results obtained in this study showed a tendency 
towards geographical variations in the presence of HTb in 
the venoms, although there were exceptions. Generally, 
venoms from snakes indigenous to southern regions of North 
and Central America had relatively high amounts of the 
toxin, while venoms from northern species tended to have 
lower amounts. For example, all of the venoms from the 
species ~ ~ pyrrhus, typically found in the Baja region 
of Mexico and in southern New Mexico, Utah and California, 
had very high amounts of HTb. c. ~ durissus, indigenous 
to Central America, also had high amounts of the toxin in 
the venom. However, the two other ~ durissus subspecies, 
c. d. totonacus and c. d. culminatus had little toxin in 
their venoms. None of the species tested from the eastern 
United States, c. ~ horridus, c. adamanteus, and C. h. 
atricaudatus, had high amounts of HTb. Bober (1987) showed 
with the ELISA a geographical variation in the distribution 
of myotoxin ~, from ~ ~ viridis venom, with a greater 
distribution of the toxin in the north and southwest 
regions of the United States, Mexico and South America. 
Bonilla and Horner (1969) made the statement, 
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" ... venoms represent body fluids whose compositions are 
characteristic for a given species," based on an 
electrophoretic analysis of Crotalus and Agkistrodon 
species. However, there are other reports describing the 
presence of cross-reacting components in venoms of 
differing species. Kaiser et al. (1986) reported the 
cross-reactivity and neutralization by rabbit antisera 
produced against crotoxin, a potent neurotoxin present in 
the venom of ~ ~ terrificus, of Mojave toxin, from the 
venom of c. s. scutulatus, and concolor toxin, from the 
venom of c. v. concolor. Glenn and Straight (1985) tested 
for the presence of mojave toxin in the venom of six 
crotalid species using immunodiffusion and found a cross-
reactive protein in the venom of c. mitchelli mitchelli. 
Rosenfeld and Kelen (1966) demonstrated cross-reacting 
antigens in the venom of multiple species from the two 
genera Bothrops and Crotalus. The use of monoclonal 
antibodies to Mojave toxin have shown the presence of 
antigenically similar components in the venoms of ~ 
basiliscus, ~ ~ durissus, ~ ~ terrificus, ~ ~ 
horridus, and~~ concolor (Rael et al., 1986). Tests 
for HTb were positive for three of these same venoms, 
clearly indicating that some venom components are not 
necessarily characteristic for a given species. 
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The determination of common components in snake venoms 
has also been used to study relationships to geographic 
distribution. Glenn and Straight (1978) reported the 
variation in toxicity of the venom from ~ ~ scutulatus 
depending on the geographical origin. There were distinct 
differences in lethality induced by the venom and the 
ability of polyvalent antivenin to neutralize lethal 
effects between venom specimens from southern California 
and those from north central and northwest Arizona. Such 
variations are very important in the consideration of 
medical treatments. Minton and Weinstein (1986) reported 
differences in proteolytic activity and lethality of c. 
atrox venom relative to geographic origin. There was no 
apparent relationship between hemorrhagic activity and 
geographical distribution. The results presented in this 
study indicate a possible geographical distribution of HTb. 
Pooling of venoms for study often "hides" variations 
in snake venoms (Glenn and Straight, 1982), a 
characteristic that should be considered important, 
especially for medical reasons. Clearly, snake venoms do 
contain common antigenic components, characteristics that 
may be exploited in developing better treatments. Common 
components may also be useful in mapping ontogenic 
relationships between species and genera. 
CHAPTER VI 
IMMUNOHISTOCHEMICAL LOCALIZATION OF 
HEMORRHAGIC TOXIN B IN SKELETAL MUSCLE 
Introduction 
Hemorrhagic toxin b is capable of causing not only 
hemorrhage, but myonecrosis as well (Ownby et al., 1978). 
It represents approximately 3.7% of the crude venom 
protein, has a molecular weight around 24,000 daltons, and 
is highly basic (Bjarnason and Tu, 1978). It is the only 
reported directly-acting myotoxin isolated from Crotalus 
atrox venom (Ownby et al., 1978). The pathogenesis of 
hemorrhage induced by HTb has been reported (Ownby et al., 
1978), and has previously been described in Chapter II. 
Myonecrosis is caused by a variety of toxins, 
including toxins that act directly on the muscle, and 
toxins which apparently act indirectly through ischemia. 
These latter toxins include viriditoxin, from ~ viridis 
viridis venom (Fabiano and Tu, 1981; Gleason et al., 1983), 
which was originally reported as a "tissue-damaging 
hemorrhagin" (Fabiano and Tu, 1981). Hemorrhagic toxin b 
has been reported to cause myonecrosis, though it was 
unclear whether the action was direct or due indirectly to 
ischemia (Ownby et al., 1978). The presence of intact 
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capillaries next to damaged muscle cells indicated a 
possible direct action of the toxin. Necrosis in muscle 
due to ischemia does not ensue until about six hours after 
the onset of the condition (Ownby and Colberg, publication 
submitted), and unlike the other hemorrhagic toxins in c. 
atrox venom, HTb causes myonecrosis by three hours in 
skeletal muscle (Ownby et al., 1978), presenting further 
evidence for a possible direct action of the toxin on 
muscle. There is only one other reported hemorrhagic 
myotoxin, mucrotoxin A from the venom of Trimeresurus 
mucrosquamatous, capable of inducing myonecrosis by three 
hours (Sugihara et al., 1983). 
There are only two reports in the literature 
describing the localization of snake venoms or their 
components in mammalian tissues. Schiff et al. (1984) 
reported the immunocytochemical localization of c. atrox 
venom in the lungs of mice using Wyeth's polyvalent 
(Crotalidae) antivenin conjugated to horse-radish 
peroxidase. Tu and Morita (1983) described the 
localization of myotoxin ~, from ~ ~ viridis venom, on 
the sarcoplasmic reticulum at the electron microscopic 
level, avoiding the use of immunoglobulins by conjugating 
myotoxin ~ with HRP directly. 
Because HTb causes hemorrhage only after a latency 
period, and since there is still some question as to the 
mechanism of induction of myonecrosis by the toxin, it 
would be useful to know whether the toxin binds to the 
capillary wall and muscle cell, and if so, at what time 
period after the injection of the toxin. Information 
concerning the binding of the toxin to the tissue could 
then be used to direct studies in the ultrastructural 
localization of the toxin. 
Material and Methods 
Hemorrhagic Toxin Q and 
Antibody Purification 
138 
HTb was isolated as previously described (Chapter 
III). Briefly, 2.0 grams of desalted crude Crotalus atrox 
venom was purified by a four-step chromatographic procedure 
utilizing anion exchange, gel filtration, cation exchange, 
and hydrophobic interaction chromatography. The purified 
toxin thus obtained contained only a single protein band 
after analysis by SDS-PAGE, and was considered homogenous. 
The toxin was desalted, diafiltered into 0.01 M Na-MOPS, pH 
7.2, and stored at -20°C until needed. 
Antibodies to HTb, subsequently referred to as primary 
antibodies, were purified using affinity chromatography as 
previously described (C~apter IV). Briefly, serum from 
rabbits immunized with HTb was applied to an affinity 
column consisting of 8.0 ml of Affi-Gel 10 (Bio-Rad Corp.) 
affinity matrix containing approximately 3.5 mg of 
covalently coupled HTb per ml. The affinity-purified 
antibodies were eluted with 0.05 M acetic acid, pH 3.0, and 
stored frozen in PBS until needed. 
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Goat anti-rabbit antibodies labelled with fluorescein 
isothiocyanate, subsequently referred to as secondary 
antibodies, were purchased from Sigma Chemical company. 
These were affinity-purified whole immunoglobulin 
molecules. 
Mice 
All experiments were performed on female white CD-1 
mice purchased from Charles River (Rockville, MD). The 
weights ranged from 25 to 30 gm. 
Immunohistochemistry: Tissue 
Preparation and Sectioning 
Four groups of five mice were injected intramuscularly 
with the toxin following cation exchange chromatography. 
Each mouse was injected in the dorsolateral aspect of the 
right thigh with 8.4 mg/kg of HTb in a volume of 0.05 ml. 
The five mice from each group were killed by cervical 
dislocation at 5 min, 30 min, 3 hr and 24 hr after toxin 
injection and samples of tissue were removed for 
processing. A fifth group of five mice received a 
physiological saline injection as a contol and the tissue 
from these mice was processed at 5 min following injection. 
The tissue was cut into approximately 1 X 1 mm blocks and 
placed in 1% freshly prepared paraformaldehyde in 0.27 M 
cacodylate buffer, pH 7.4, for 1 hr. The tissue was washed 
3 X 10 min with 0.27 M cacodylate buffer, washed for 30 min 
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in 0.02 M glycine, 0.15 M sodium chloride, 0.01 M sodium 
phosphate, pH 7.4, to block unreacted formaldehyde groups, 
and then placed in 1% gelatin for 30 min. The tissue 
blocks were mounted on cork bases with OCT compound (Lab-
Tek Products, Naperville, IL) and rapid frozen in acetone 
cooled to -60°C with dry ice. Sections of approximately 
eight micron thickness cut using a SLEE cryostat (SLEE 
Corp., London, England) and collected on glass slides 
coated with poly-L-lysine (Sigma Chemical Co.). 
Immunohistochemistry: Staining 
The sections were allowed to warm to room temperature, 
at which time they were rehydrated for 10 min in PBS and 
subsequently treated with 0.02 M glycine in PBS for 10 min. 
The sections were washed 2 X 1 min with PBS and placed in a 
1/20 dilution of normal goat serum for 1 hr. After washing 
4 X 5 min in PBS, 0.2 ml of a 0.05 mg/ml solution of 
primary antibodies was applied to the sections and allowed 
to react overnight at 4°C in a humid chamber. The sections 
were washed 4 X 5 min with PBS and 0.1 ml of a 1/500 
dilution of secondary antibodies conjugated with FITC was 
applied to the sections and allowed to react for 2 hr in a 
humid chamber. The sections were washed 4 X 5 min in PBS 
and placed under coverslips in a 50% glycerol (in PBS) 
solution. The antibody solutions were always centrifuged 
for 2 min in an Brinkmann Microfuge to remove any 
aggregated material. The sections were examined 
immediately after staining with a Carl Zeiss incident 
fluorescence microscope with the following filters: (1) 
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excitation filter, BP 485/20; (2) beam splitter filter, FT 
510; and (3) barrier filter, LP 520. Photographs were 
taken using Kodak ektachrome PS00/1600 film exposed during 
photography for two minutes. 
Three control staining solutions were also 
incorporated on serial sections of the tissue: (a) a PBS 
control, which included treatment of the section with PBS 
in place of primary and secondary antibody solutions; (b) a 
secondary antibody control, which included treatment of the 
section with PBS in place of primary antibody; and (c) a 
preabsorbed antibody control, which included treatment of 
the section with the preabsorbed antibody solution in place 
of the primary antibody. The preabsorbed antibody was 
prepared by mixing 45 mg HTb per mg primary antibody. The 
0 
mixture was allowed to react overnight at 4 C, followed by 
centrifugation in a Brinkmann microfuge. 
Histology 
A serial section of the frozen tissue was always 
stained with Multiple Stain for frozen sections 
(Polysciences, Inc, Warrington, PA). A section of the 
muscle used for the immunohistochemical localization was 
also prepared for plastic embedding. The tissue was fixed 
for 2 hr in 1% glutaraldehyde, followed by washing and 
fixation with 0.5% osmium tetroxide for 1 hr. The tissue 
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was subjected to dehydration in acetone and placed in Poly 
Bed 812 (Polysciences, Inc.) plastic resin. One micron 
thick sections were cut using a Sorvall MT-5000 
ultramicrotome (Dupont Corp.) and stained with Mallory's 
trichrome stain. Photographs were taken with a Nikon 
(Garden City, NY) Labophot microscope equipped with a UFX 
II photomicrographic attachment. 
Results 
Preliminary Studies 
Several preliminary studies were performed in order to 
optimize the conditions for the experiments. (1) Several 
dilutions of primary and secondary antibody solutions were 
tested to determine the lowest possible concentrations of 
antibodies that could be used so as to reduce the chances 
of nonspecific reactions; (2) fixation in 1% 
glutaraldehyde, 0.5% glutaraldehyde with 1% 
paraformaldehyde, and 1% paraformaldehyde was evaluated to 
determine which fixative could be used without destroying 
antigenicity of the toxin; and (3) the tissue was also 
sectioned with and without pretreatment with 1% gelatin to 
determine if the treatment stabilized the tissue during 
sectioning. The preliminary studies showed that the 
primary antibody solution was optimal at 0.05 mg/ml while 
the secondary antibody solution, purchased from Sigma 
Chemical Co., was optimal at a 1/500 dilution, which was 
approximately 0.002 mg/ml. Treatment of the sections with 
--- ---------
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either of the fixatives containing glutaraldehyde resulted 
in no fluorescence of the tissues receiving treatment with 
primary and secondary antibodies. Only fixation with 1% 
paraformaldehyde resulted in fluorescence. The treatment 
with gelatin stabilized the tissue during sectioning. This 
was unnecessary at the 5 and 30 min time periods, but was 
helpful at the 3 and 24 hour time periods. At these time 
periods, the extensive edema resulted in a marked loss of 
integrity of the tissue. 
Figure 14 shows the results for the control on 
specific toxin binding, i.e., tissue from mice receiving no 
toxin. The PBS (Figure 14A) and secondary antibody (Figure 
14B) control sections had some autofluorescence. It was 
predominantly the smaller muscle cells in the tissue that 
autofluoresced, usually around the periphery of the cell. 
When viewed with the microscope, this fluorescence was 
noticeably more yellow than the fluorescence of the FITC, 
which was bright green. In the preabsorbed antibody 
control sections (Figure 14C), the entire muscle cell 
fluoresced, although at a low intensity. Figure 14D shows 
that there was no specific fluorescence after treatment of 
the section with primary and secondary antibodies, which 
was expected since no toxin was introduced into the tissue. 
This excludes the possibility of non-specific binding of 
the primary or secondary antibody to the tissue. The 
normal morphology of the tissue is seen in Figures 14E and 
14F. 
Figure 14. Light micrographs of sections of muscle from 
control mice which were not injected with 
HTb. 
(A) PBS control - no primary or secondary 
antibody; 
(B) Secondary antibody control - no primary 
antibody; 
(C) Preabsorbed antibody control; 
(D) Section treated with both primary and 
secondary antibodies; 
(E) Untreated frozen section stained with 
Multiple Stain; 
(F) Plastic embedded tissue section. 
M = normal muscle cell. 

146 
Figure 15 shows the results of the localization of HTb 
in muscle tissue removed 5 min after injection of the 
toxin. The PBS (Figure 15A) and secondary antibody (Figure 
15B) control sections had some endogenous fluorescence. 
The preabsorbed antibody control section (Figure 15C) had 
cells that also fluoresced in their entirety. Figure 15D 
shows a section treated with both primary and secondary 
antibodies. There was a bright, specific fluorescence 
around the periphery of the muscle cells. However, only 10 
to 20% of the cells within the section demonstrated 
fluorescence at the 5 min period. Binding of the toxin to 
capillary walls was not detected since the fluorescence 
around the muscle cell was so intense. There was no edema 
to allow separation of the muscle cells and thus 
visualization of the capillaries. No fluorescence was seen 
in the connective tissue spaces where binding to 
capillaries would occur. Figure 15E is the section of 
muscle stained with Multiple Stain, and Figure 15F is the 
plastic embedded tissue, allowing visualization of the 
muscle section morphology. None of the cells appeared 
damaged and no hemorrhage was present. 
Figure 16 shows the results of the localization of HTb 
at 30 min following toxin injection. The control sections, 
Figures 16A-C, had the same basic pattern described above. 
However, there was fluorescence over a larger portion of 
the section treated with primary and secondary antibodies 
(Figure 16D). Again, the fluorescence was very intense at 
Figure 15. Light micrographs of sections of murine muscle 
taken 5 min following injection of HTb. 
(A) PBS control - no primary or secondary 
antibody; 
(B) Secondary antibody control - no primary 
antibody; 
(C) Preabsorbed antibody control; 
(D) Section treated with both primary and 
secondary antibodies; 
(E) Untreated frozen section stained with 
Multiple Stain; 
(F) Plastic embedded tissue section. M = 
normal muscle cell. Note fluroescence at 
arrow. 

Figure 16. Light micrographs of sections of murine muscle 
taken 30 min following injection of HTb. 
(A) PBS control - no primary or secondary 
antibody; 
(B) Secondary antibody control - no primary 
antibody; 
(C) Preabsorbed antibody control; 
(D) Section treated with both primary and 
secondary antibodies; 
(E) Untreated frozen section stained with 
Multiple Stain; 
(F) Plastic embedded tissue section. 
M = normal muscle cell. Note fluorescence at 
arrow. 
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the muscle cell periphery, and determination of toxin 
binding to the capillaries in this region was not possible. 
Approximately 70% of the cells observed showed binding of 
the toxin. The areas that did have fluorescence appeared 
to be of homogeneous intensity, as with 5 min post-
injection, though slightly more intense than at five 
minutes. Figure 16E is the untreated frozen section of 
muscle stained with Multiple Satin and Figure 16F is the 
plastic embedded tissue, again demonstrating relatively 
normal morphology and no hemorrhage. 
Figure 17 shows the results of localization of HTb at 
3 hr after toxin injection. The control sections, Figures 
17A-C, were similar to those described above for 5 and 30 
min. However, treatment with secondary antibody control 
solution (Figure 17B) resulted in the specific green 
fluorescence of erythrocytes, making it impossible to 
visualize any reaction of the toxin with capillaries. By 3 
hr following injection of the toxin, severe hemorrhage and 
some myonecrosis was observed, and virtually all of the 
cells observed had fluorescence at the muscle cell 
periphery (Figure 17D). The section receiving the 
Multiple Stain (Figure 17E), and the plastic embedded 
tissue section (Figure 17F), showed that hemorrhage and 
myonecrosis had developed by this time period. The tissue 
was edematous, making sectioning difficult. 
Figure 18 shows the results of the localization at 24 
hr after toxin injection. The PBS and secondary antibody 
Figure 17. Light micrographs of sections of murine muscle 
taken 3 hr following injection of HTb. 
(A) PBS control - no primary or secondary 
antibody; 
(B) Secondary antibody control - no primary 
antibody; 
(C) Preabsorbed antibody control; 
(D) Section treated with both primary and 
secondary antibodies; 
(E) Untreated frozen section stained with 
Multiple Stain; 
(F) Plastic embedded tissue section. 
M = normal muscle cell; N = necrotic muscle 
cell. Note fluorescence at arrow. 

Figure 18. Light micrographs of sections of murine muscle· 
taken 24 hr following injection of HTb. (A) PBS control - no primary or secondary 
antibody; 
(B) Secondary antibody control - no primary 
antibody; 
(C) Preabsorbed antibody control; 
(D) Section treated with both primary and 
secondary antibodies; 
(E) Untreated frozen section stained with 
Multiple Stain; 
(F) Plastic embedded tissue section. 
M = normal muscle cell; N = necrotic muscle 
cell. 
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control sections, Figures 18A and 18B, showed an increase 
in the autofluorescence of the tissue. The preabsorbed 
antibody control section was similar to that observed with 
the three hour time period. By this time period, severe 
myonecrosis and hemorrhage was observed (Figures 18E and 
18F). The necrotic cells included those with clumped 
myofilaments, delta lesions, and cells with a hyaline 
appearance. In some cases, only remnants of the cell 
membrane and basal lamina were visible. It was difficult 
to determine if the toxin was still associated with the 
muscle cell periphery based on the fluorescence because of 
the severity of the necrosis. There was some fluorescence 
associated with the muscle cells (Figure 18D), but much of 
the fluorescence was yellow, i.e., autofluorescence. Some 
of the cells fluoresced entirely, similar to that observed 
with the preabsorbed antibody controls, although the state 
of the muscle precluded any definitive conclusions 
concerning this. Also at this time period, the 
erythrocytes fluoresced following treatment with the 
secondary antibody control solution. Figures 18E and 18F 
are the frozen and plastic embedded tissue sections, 
clearly demonstrating the degree and extent of myonecrosis 
by this time period. 
Discussion 
The results presented here demonstrate that HTb 
clearly binds to the muscle cell, offering further evidence 
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that this toxin is indeed a direct-acting myotoxin as well 
as a hemorrhagic toxin. Fabiano and Tu (1981) reported the 
isolation of a tissue-damaging toxin, viriditoxin, from the 
venom of ~ ~ viridis, capable of inducing hemorrhage and 
myonecrosis. However, Gleason et al. (1983), showed that 
the myotoxic effect of this toxin was most likely due to 
myonecrosis resulting from ischemia, since necrosis was not 
seen until after the onset of ischemic conditions. HTb is 
different from viriditoxin in that myonecrosis is observed 
three hours after toxin injection (Ownby et al., 1978), 
indicating a possible direct action of the toxin on the 
muscle. The results presented here on the localization of 
the toxin support this hypothesis. 
The binding of the toxin appeared to be an all-or-none 
type of binding, since the degree of fluorescence appeared 
to be relatively the same for all time periods for which it 
was observed, with differences only in the number of cells 
showing binding. The fluorescence observed at five minutes 
was only slightly less intense than at other time periods. 
Apparently a major limiting factor to the distribution of 
the toxin throughout the tissue is diffusion, though 
additional studies would be required to allow a conclusive 
statement. It was not possible to determine if the toxin 
was retained by the muscle cells at 24 hr after injection 
due to the severity of myonecrosis. There was fluorescence 
at the periphery of some cells, but the majority of it was 
yellow, which is indicative of autofluorescence. Some of 
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the cells did have green fluorescence due to FITC in their 
interior, which indicates a possible internalization of the 
toxin. However, the degree of necrosis and the state of 
the muscle cells at this time period prevented any definite 
conclusions concerning this. 
The fluorescent antibody technique did not allow for 
determination of toxin binding to the capillary wall since 
the secondary antibody reacted, perhaps nonspecifically, 
with erythrocytes at the 3 and 24 hr time periods following 
toxin injection. This was compounded by the degree of 
fluorescence at the periphery of the muscle cells, although 
no binding of the toxin to vessels in the interstitial 
spaces was observed at 5 or 30 min. 
The preabsorbed antibody control sections had cells 
that fluoresced entirely despite the use of excessive 
amounts of toxin. It is possible that the antibodies did 
not bind the tissue-binding region of the toxin, which 
would allow nonspecific binding of the toxin/antibody 
complexes to the tissue, explaining the fluorescence 
throughout the cell. Unpublished results (Chapter IV) 
demonstrated the poor ability of the affinity-purified 
antibodies to neutralize hemorrhage, neutralization 
occurring only when the antibodies were in extreme excess. 
These results possibly offer some support for the idea that 
the antibodies bind a region or regions of the toxin 
different from the tissue-binding region of HTb. However, 
further studies must be done on the mechanism of action of 
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the toxin for the induction of hemorrhage and myonecrosis 
before acceptance of this hypothesis is possible, since the 
active site of the toxin may be different for the two 
different effects. 
OWnby et al. (1978) described the pathogenesis of 
hemorrhage induced by HTb. The endothelial cells were 
described as becoming very thin prior to rupture, even 
adjacent to intact intercellular junctions, resulting in 
hemorrhage per rhexis. Fox et al. (1986) proposed that 
disruption of the collagenous material around the capillary 
aids in hemorrhage. HTb has been shown to disrupt the 
basal lamina (OWnby et al., 1978), perhaps due to its 
proteolytic capabilities, suppo~ting the view of Fox et al. 
(1986). HTb is capable of degrading casein (Bjarnason and 
Tu, 1978), fibrinogen (Komori et al., 1985), and insulin B 
chain (Hagihara et al., 1985), though there is no report in 
the literature of it's activity on collagen. It is of 
interest to know if the toxin does bind the capillary wall, 
and if so, whether it binds the basal lamina, the 
endothelial cell, or both. Demonstration of this would 
require an electron microscopic study. However, 
preliminary studies for the work presented here showed that 
fixation with glutaraldehyde apparently destroyed the 
antigenicity of the toxin. As cross-linking fixatives such 
as glutaraldehyde are usually required for adequate 
preservation of cell ultrastructure, this approach is not 
currently feasible. Efforts to develop a fixation method 
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that would not destroy the antigenicity of the toxin would 
be required before such an ultrastructural study could be 
undertaken. 
Tu and Morita (1983) reported the localization of 
myotoxin ~ to the sarcoplasmic reticulum using horse-radish 
peroxidase conjugated directly to the toxin. Such a 
technique would not be affected by the fixation method 
used. However, one could not be sure that the HRP label 
did not affect the "normal" distribution of the toxin in 
the tissue, creating some questions as to the results of 
such a localization study. 
CHAPTER VII 
SUMMARY AND CONCLUSIONS 
Hemorrhagic toxin b has been isolated by anion 
exchange, molecular sieve, cation exchange, and hydrophobic 
interaction chromatography from the venom of Crotalus 
atrox. Homogeneity was demonstrated with SDS 
polyacrylamide gel electrophoresis. The toxin has a highly 
basic isoelectric point, above 10.5, and proteolytic 
activity with dimethylcasein as the substrate, 
demonstrating a broad pH optimum. It is a single 
polypeptide with a molecular weight of approximately 23,000 
daltons. It demonstrates no phospholipase or arginine 
esterase activities, and represents approximately 3.5% of 
the crude venom protein. The toxin has a minimum 
hemorrhagic dose of 0.3 mg/kg in mice, as measured with the 
method of Kondo (1960); to be compared with a minimum 
hemorrhagic dose of 0.2 mg/kg for crude c. atrox venom. 
HTb is a peculiar toxin as compared to other 
hemorrhagic toxins. It is the most highly basic 
hemorrhagic toxin reported, although many of the toxins 
have not had specific isoelectric points determined. This 
toxin also induces myonecrosis directly, evident by the 
presence of necrotic muscle cells by three hours after 
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toxin injection, as opposed to necrosis due to ischemia, 
which requires at least six hours (C. L. OWnby, personal 
communication). The only other direct acting hemorrhagic 
myotoxin reported in the literature is mucrotoxin A, from 
~ mucrosguamatous venom, which is a high molecular weight 
toxin with an acidic isoelectric point. HTb also differs 
from the other hemorrhagic toxins isolated from c. atrox 
venom in that hemorrhage does not appear until at least 
twenty minutes following toxin injection. Histologically, 
muscle treated with HTb appears completely normal until 
after this latent time period, after which hemorrhage 
increases gradually to a maximum. 
Antibodies to HTb have been affinity-purified from the 
serum of rabbits immunized with the toxin using an affinity 
column containing HTb coupled to an Affi-Gel 10 matrix. 
Partial neutralization of hemorrhage was observed when the 
antibody/toxin weight ratio was 58.58 mg/1.0 mg. Complete 
neutralization required a ratio of 104.6 mg/1.0 mg. 
The enzyme-linked immunosorbent assay was used to 
detect the presence of HTb in the venom of fifty-three 
species and subspecies of snakes. The venoms were 
collected from snakes captured in Mexico, Costa Rica, and 
ten different states of the United States. In some cases, 
the origin of the venom was unknown. Of the five genera 
tested, Crotalus, Agkistrodon, Bothrops, and Trimeresurus 
had venoms that tested positive. The venom from Naja 
kaouthia, the only representative of this genus, tested 
r 
negative. Forty of the fifty-three venom samples tested 
positive, which represents over 75% of those tested. Ten 
of these venoms had detectable levels of HTb at a 
concentration 0.001 mg/ml, the highest dilution measured. 
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The results of the assay for the presence of HTb 
illustrated a tendency towards a geographic variation 
relative to HTb content. None of the species evaluated 
from the eastern United States had appreciable amounts of 
the toxin in their venoms, while there seemed to be a 
north-south variation with venoms from species typically 
found in the southern regions of the United States, Mexico 
and Central America having the greatest amounts of HTb. 
There also was marked variation in the venom content of HTb 
within specific genera as well as within species and 
subspecies. 
Because of the question concerning the direct myotoxic 
action of HTb, the toxin was localized in skeletal muscle 
at the light microscopic level using immunohistochemical 
techniques. The toxin was shown to bind the muscle cell 
within five minutes following injection of the toxin. The 
only apparent limitation to the distribution of the toxin 
and it's subsequent binding to the muscle cells was 
diffusion, although the results presented here cannot offer 
definitive conclusions concerning this. Although no 
attempts were made to quantitate the number of cells 
demonstrating binding of the toxin, visual inspection 
showed that approximately 10-20% of the cells had bound the 
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toxin by five minutes. By thirty minutes, approximately 
60-70% of the cells demonstrated binding, and by three 
hours post-injection, all of the cells observed showed 
binding of the toxin. It was not possible to determine the 
state of toxin binding at twenty-four hours following 
injection of the toxin due to the advanced state of 
necrosis. 
It was impossible to determine when the toxin bound 
the capillaries, if such binding occurred at all, for 
several reasons. The degree of fluorescence around the 
periphery of the muscle cell was too intense to determine 
if there was any fluorescence at the capillaries in the 
region between the cells. Also, at the early time periods, 
five and thirty minutes, the lack of severe hemorrhage and 
edema did not allow for separation of the muscle cells, 
compounding the problem of observing the capillaries in 
these regions. However, there was no fluorescence around 
capillaries in the interstital spaces at five and thirty 
minutes after toxin injection, indicating that no binding 
had occurred by this time period. At three and twenty-four 
hours post-injection, the secondary antibodies 
nonspecifically bound the extravasated erythrocytes, 
precluding any determination of capillary binding. The 
presence of intact capillaries next to necrotic muscle 
cells and the onset of necrosis by three hours following 
injection of the toxin (Ownby et al., 1978), coupled with 
the information presented here showing that the toxin does 
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bind muscle cells within five minutes following injection, 
strongly indicates that HTb does have direct myotoxic 
activity. 
There are many reasons for studying snake venoms, but 
two of the most important should be (1) to develop better 
methods of treating clinical cases, and (2) to better 
understand the characteristics of the toxins in venoms so 
that we may better understand the pathogenesis of their 
toxic activities. The development of better treatments is 
completely dependent on the understanding of pathogenesis 
and mechanisms of actions of toxic components. It is this 
dependency upon which the work presented here was based. 
By isolating and studying a single toxin, some insight may 
be offered concerning the effects of the whole venom. 
Hopefully, the results presented in this paper will aid in 
a more complete understanding of c. atrox venom poisoning, 
in addition to exposing some questions to be further 
studied. These questions might include an ultrastructural 
localization of the toxin to determine what morphological 
structure or structures are affected by the toxin. 
Because HTb induces both myonecrosis and hemorrhage, 
and represents 3.5% of the crude venom, it would seem that 
this toxin would play a decisive role in the local tissue 
damage following c. atrox envenomation. Although Wyeth's 
polyvalent (Crotalidae) antivenin, the antiserum most 
commonly used for rattlesnake venom poisoning, was shown to 
be effective against hemorrhage induced by ~ atrox venom 
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(OWnby et al., 1984b), the results presented here 
demonstrated no neutralization (in vitro) of even one 
minimum hemorrhagic dose of HTb. Because so many other 
crotalid venoms have a toxin that cross-reacts with 
antibodies produced against HTb, many of which may have 
tissue-damaging effects similar to HTb, an antiserum should 
have, at the least, some neutralizing capacity for such a 
toxin. It is hoped that the results presented in this 
paper may be used to develop treatments that will prove 
effective against toxins like HTb and, ultimately, against 
the crude venoms. 
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